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Here we present complete genome sequences, including a comparative analysis, of 103 isolates of foot-and-
mouth disease virus (FMDV) representing all seven serotypes and including the first complete sequences of the
SAT1 and SAT3 genomes. The data reveal novel highly conserved genomic regions, indicating functional
constraints for variability as well as novel viral genomic motifs with likely biological relevance. Previously
undescribed invariant motifs were identified in the 5 and 3 untranslated regions (UTR), as was tolerance for
insertions/deletions in the 5 UTR. Fifty-eight percent of the amino acids encoded by FMDV isolates are
invariant, suggesting that these residues are critical for virus biology. Novel, conserved sequence motifs with
likely functional significance were identified within proteins Lpro, 1B, 1D, and 3C. An analysis of the complete
FMDV genomes indicated phylogenetic incongruities between different genomic regions which were suggestive
of interserotypic recombination. Additionally, a novel SAT virus lineage containing nonstructural protein-
encoding regions distinct from other SAT and Euroasiatic lineages was identified. Insights into viral RNA
sequence conservation and variability and genetic diversity in nature will likely impact our understanding of
FMDV infections, host range, and transmission.
Foot-and-mouth disease (FMD) is an acute, systemic dis-
ease of domestic and wild cloven-hooved animal species and is
caused by Foot-and-mouth disease virus (FMDV), the proto-
type member of the genus Aphthovirus of the family Picorna-
viridae. FMDV occurs as seven distinct serotypes (Euroasiatic
serotypes A, O, C, and Asia1 and South African Territories
[SAT] serotypes SAT1, SAT2, and SAT3) and multiple sub-
types reflecting significant genetic variability. The highly con-
tagious nature of FMDV and the associated productivity losses
make it a primary animal health concern worldwide. Effective
vaccines and stringent control measures have enabled FMD
eradication in most developed countries, which maintain un-
vaccinated, seronegative herds in compliance with strict inter-
national trade policies. However, the disease remains enzootic
in many regions of the world, posing a serious problem for
commercial trade with FMD-free countries.
FMDV is a small nonenveloped virus with a pseudo T3
icosahedral capsid made up of 60 copies each of four structural
proteins. The capsid surrounds an 8.4-kilobase, positive-sense,
single-stranded RNA genome which is covalently bound at its
5 end to the small viral protein 3B (or VPg) and is polyade-
nylated at its 3 end. Upon virus entry into a cell, the viral
genome is rapidly translated into a polyprotein which is co- and
posttranslationally cleaved by viral proteinases into several
partially cleaved, likely functional, intermediates and ulti-
mately into 12 mature proteins (87, 97).
The FMDV genome organization is similar to that of other
picornaviruses, including a large single open reading frame
(ORF) flanked by highly structured 5 and 3 untranslated
regions (5 UTR and 3 UTR, respectively) (Fig. 1A). The 5
UTR consists of, from the 5 end, a 350- to 380-nucleotide (nt)
“short” (S) fragment, a 100- to 420-nt poly(C) tract (90% C),
and the approximately 700-nt 5 terminus of the genomic
“long” (L) fragment, which contains three or four tandemly
repeated pseudoknots, a stem-loop cis-acting replication ele-
ment (cre), and a type II internal ribosome entry site (IRES)
(69). The FMDV 5 UTR plays important roles in cap-inde-
pendent translation initiation of the viral polyprotein and in
viral genome replication (64). The 3 UTR is about 90 nt long
and is thought to contain cis-acting elements required for ef-
ficient genome replication (4).
The four capsid proteins, 1A, 1B, 1C, and 1D (also known as
VP4, VP2, VP3, and VP1, respectively), are encoded by the
N-terminal half of the ORF, and with the exception of 1A,
which is excluded from the virion surface, are involved in
antigenicity and binding to a subset of RGD-dependent inte-
grins and heparan sulfate proteoglycan receptors on the cell
surface (reviewed in reference 45). Nonstructural proteins rep-
resent about two-thirds of the ORF-encoded proteins and in-
clude Lpro, 2A, 2B, 2C, 3A, 3B, 3Cpro, and 3Dpol (93). FMDV
polyprotein processing is mediated by Lpro, 3Cpro, and 2A. Lpro
is a papain-like protease that, in addition to excising itself from
the polyprotein, cleaves the cellular translation initiation factor
eIF4G, resulting in a shutoff of host cap-dependent translation
(65). 3Cpro, a member of the trypsin family of serine protein-
ases, performs all but three of the cleavages leading to mature
viral proteins and also cleaves host cell proteins (111). FMDV
2A mediates autocleavage at its C terminus, apparently by
* Corresponding author. Mailing address: Department of Pathobi-
ology and Veterinary Science, University of Connecticut, 61 N. Ea-
gleville Road, Unit-3089, Storrs, CT 06269-3089. Phone: (860) 486-
2845. Fax: (860) 486-2794. E-mail: drock@cshore.com.
† Supplemental material for this article may be found at http:
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inducing a ribosomal skip during polyprotein synthesis (19, 20).
Although the functions of the FMDV 2B and 2C proteins are
unknown, preliminary work suggests that, similar to those of
other picornaviruses, they localize to endoplasmic reticulum
(ER)-derived vesicles, the sites of viral genome replication
(106). 3A is thought to be a multifunctional integral membrane
protein that enhances viral RNA synthesis by 3Dpol and stim-
ulates cleavage of the 3CD precursor (91). FMDV encodes
three nonidentical copies of genome-linked 3B, a protein re-
quired for viral RNA replication (26). The 3D gene encodes
the viral RNA-dependent RNA polymerase, and it and 3A
colocalize with ER membrane-associated replication com-
plexes (80, 92).
Despite a basic understanding of many aspects of picorna-
viral biology, much information regarding FMDV UTR, pro-
tein, and protein precursor functions and roles in virulence,
host range, and virus transmission remains poorly understood.
Comparative genomic analysis of a large number of FMDV
genomes may allow the identification of highly conserved reg-
ulatory or coding regions which are critical for aspects of virus
biology. To date, the few comparative analyses of full-length
FMDV genomes have relied on intratypic (serotype O) or
intertypic (serotypes O, A, and C) comparisons of a small
number of isolates and serotypes (70, 86). In addition, com-
plete genomic sequences of some serotypes are not available
(SAT1 and SAT3) or, for others, only represent highly cell
culture-adapted isolates (serotypes A and C). Studies involving
large numbers of virus isolates have largely focused on
genomic regions encoding structural proteins associated with
serotype specificity for phylogenetic purposes (reviewed in ref-
erence 55).
For this work, we obtained and analyzed 103 complete ge-
FIG. 1. FMDV UTR variability. (A) FMDV S and L genomic fragments showing the locations and predicted secondary structures of UTRs.
Cn, poly(C) tract; AUG, start codons; pAn, poly(A); I, II, and III, S fragment, IRES, and 3 UTR, respectively. (B) Rates of substitution per nt
between positions 1 and 1218 and positions 8277 and 8441 in a genomic ClustalW alignment. Arrows with numbers indicate positions with high
rates of nt substitution. (C) 5 UTR nt conservation between positions 1 and 1153 for the 103 FMDV isolates examined in this study. Motifs
previously defined as conserved between picornavirus IRESs are underlined. Boxes indicate primers used for amplification. Asterisks indicate nt
positions tolerant to insertions/deletions in two or more isolates. (D) Nucleotide conservation within S fragment (I), IRES (II), and 3 UTR (III)
predicted secondary structures. Arrows indicate regions used for PCR amplification. UTR regions from the isolate C5Argentina/69 were used to
generate secondary structure predictions and plots with mfold and Squiggles. Black circles indicate invariant nt among the 103 isolates presented
here; gray circles represent nt that are conserved in at least 100 of 103 isolates (96%); gray shading indicates residues comprising previously
described motifs. Nucleotide position numbers correspond to the consensus sequence generated by a ClustalW alignment of the 103 isolates.
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nome sequences representing all FMDV serotypes, including
the previously unavailable SAT1 and SAT3 genomes. Our
analyses identified novel highly conserved genomic regions in-
dicating functional constraints for variability, novel viral
genomic motifs with likely biological relevance, and previously
undescribed virus lineages.
MATERIALS AND METHODS
FMDV isolates. One hundred three FMDV isolates were obtained from the
Animal Plant Health Inspection Service, United States Department of Agricul-
ture (Table 1). Except for recent isolates from Argentina, the United Kingdom,
and South Korea (2000-2001), most isolates belonged to the Animal Plant Health
Inspection Service archive collection and represented a broad temporal and
geographical distribution (Table 1). Although certain archive isolates have been
adapted to guinea pigs or passaged in cell cultures, isolates obtained from their
natural hosts were well represented. For some analyses, complete genome or
whole polyprotein FMDV sequences currently available in GenBank release 141
were considered and included (Table 1).
FMDV RNA isolation, RT-PCR amplification, and sequencing. Full-length
FMDV genome sequences were obtained by reverse transcription (RT) of the
complete viral genomic RNA followed by redundant amplification and sequenc-
ing of overlapping cDNA fragments spanning the entire viral genome. The total
RNA was extracted directly from 140 l of vesicular fluid, the supernatants of
infected cell cultures, or 0.1 g of epithelial tissue from vesicular lesions by the use
of RNeasy Mini kits (QIAGEN) and was then resuspended in 40 l of double-
distilled H2O.
Complete viral genomes were reverse transcribed to cDNAs by use of a Super
SMART PCR cDNA synthesis kit (Clontech), using the supplied modified oli-
go(dT) according to the manufacturer’s instructions. After spin column purifi-
cation, the full-length double-stranded cDNA from each isolate was amplified in
eight identical long-distance PCRs (2 l cDNA in a 50-l reaction volume; 20
cycles of 95°C for 15 s, 65°C for 15 s, and 68°C for 2 min) using primers supplied
in the kit. Next, 21 overlapping 1.2-kb PCR amplicons spanning the whole
FMDV genome were generated in 96-well plates (2.5 l of template from each
of the eight double-stranded cDNA replicates in 25-l reactions using the prim-
ers described in Table S1 in the supplemental material). Adjacent amplicons
overlapped for 50% of their lengths. To prevent truncation by subsequent
rounds of PCR, we artificially created poly(C) sequences by substituting flanking
sequences with specific primers (F1R and F2F) containing six C’s or G’s.
Amplified products of the correct size were purified (DNA filtration system;
Eppendorf) and resuspended in 40 l of sterile double-distilled H2O per well. All
amplicon replicates (eight per FMDV subgenomic fragment per isolate) were
subjected to direct sequencing (2.5 l of template per reaction) using position-
specific forward and reverse primers (see Table S2 in the supplemental material),
Big Dye Terminator cycle sequencing kits (Applied Biosystems), and a PRISM
3730xl automated DNA sequencer (Applied Biosystems). To overcome virus
variability and PCR/sequencing errors, we sequenced each amplicon in multiple
reactions with both forward and reverse primers, specifically selected by serotype
(see Table S2 in the supplemental material). Since each amplicon overlapped its
neighbor 50%, the multiple direct sequencing reactions resulted in a redun-
FIG. 1—Continued.
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TABLE 1. FMDV sequences
Sequence
no.c Isolate name
a Country, year of isolation Passage historyb Accessionno.
1 A25 Argentina/59 Argentina, 1959 GP, 1 LK AY593769
2 A Canefa 1/61 Argentina, 1961 BOV 2 LK AY593789
3 A24 Argentina/65 Argentina, 1965 BOV, 3 LK AY593767
4 A26 Argentina/66 Argentina, 1966 8 GP AY593770
5 A Argentina/00 Argentina, 2000 BOV AY593782
6 A Argentina/01 Areco Argentina, 2001 BOV AY593783
7 A ARGp55/01 Argentina, 2001 BHK-21 passage 55 AY593784
8 A ARGp64/01 Argentina, 2001 BHK-21, passage 64 AY593785
9 A Trenquelauquen/01 Argentina, 2001 BOV AY593786
10 A General Lopez/01 Argentina, 2001 BOV AY593790
11 A Uruguay/01 Uruguay, 2001 BOV AY593801
12 A Uruguay/98 Uruguay, 2001 BHK-21 AY593802
13 A Bage/77 Brazil, 1977 2 BTT AY593787
14 A Brazil/79 Brazil, 1979 1 BHK-21, 1 IBRS-2 AY593788
15 A Venceslau/76 Brazil, 1976 5 BHK-21, BTT AY593803
16 A13 Brazil /70 Brazil, 1970 7 GP AY593753
17 A16 Belem/59 Brazil, 1959 BOV, 1 LK AY593756
18 A17 Aguarulbos/67 Brazil, 1967 3 BOV, 3 LK AY593757
19 A24 Cruzeiro/55 Brazil, 1955 5 BHK-21, 5 IBRS-2 AY593768
20 A Sabana/85 Colombia, 1985 1 BTT, 1 BHK-21, 1 IBRS-2 AY593794
21 A27 Colombia/67 Colombia, 1967 10 GP AY593771
22 A29 Peru/69 Peru, 1969 GP, 1 LK AY593773
23 A18 Zulia/67 Venezuela, 1967 1 BK, 10 GP, 2 LK AY593758
24 A32 Venezuela/70 Venezuela, 1970 1 BOV, LK AY593775
25 A10 Holland/42 Holland, 1942 1 IBRS-2 AY593751
26 A12 Valle Strain 119 Great Britain, 1932 77 BOV AY593752
27 A1 Bayern/Bavaria Germany, 1971 GP, 1 IBRS-2 AY593759
28 A3 Mecklenburg/68 Germany, 1968 1 BOV, 1 LK AY593776
29 A5 Westerwald/51 West Germany, 1951 ET, BTT AY593781
30 A4 WG/42 West Germany 4 BTT, 4 BHK-21 AY593777
31 A4 WG/72 West Germany, 1972 1 BOV, 1 LK AY593779
32 A5 Allier/60 France, 1960 3 GP, 4 BT, 4 BHK-21 AY593780
33 A8 Parma/62 Italy, 1962 BOV, 1 LK AY593792
34 A4 Spain Spain ET, 1 BTT AY593778
35 A2 Spain/69 Spain, 1969 1 LK AY593774
36 A14 Spain/59 Spain, 1959 BOV, 1 LK AY593754
37 A Philippines/75 Philippines, 1975 4 GP, 2 LK AY593793
38 A15 Thailand/60 Thailand, 1960 1 BOV, 3 LK AY593755
39 A22 Turkey/65 Turkey, 1965 2 BTT AY593765
40 A28 Turkey/72 Turkey, 1972 1 LK AY593772
41 A20 USSR 1/64 USSR, 1964 2 LK AY593760
42 A Iran/1/98 Iran, 1998 1 BOV AY593791
43 A22 Iraq 24/64 Iraq, 1964 4 BTT, 1 LK AY593762
44 A22 Iraq 26/64 Iraq, 1964 3 BOV AY593763
45 A22 Iraq/70 Iraq, 1970 2 LK AY593764
46 A21 Kenya/64 Kenya, 1964 9 GP AY593761
47 A23 Kenya 6/65 Kenya, 1965 2 LK AY593766
48 Asia 1 Leb 1/83 Kfar Kela/Lebanon, 1983 2 PK, 2 BTT AY593799
49 Asia 1 Leb 2/83 Lebanon, 1983 2 BOV AY593800
50 Asia 1 Leb 3/83 Southern Lebanon, 1983 2 PK, 2 BTT AY593798
51 Asia 1/1 PAK/54 Pakistan, 1954 6 BTT, 2 LK AY593795
52 Asia 1/2 ISRL 3/63 Israel, 1963 BOV, 7 GP AY593796
53 Asia 1/3 Kimron Israel, 1963 BOV, 9 GP AY593797
54 C Waldman strain 149 Great Britain, 1970 BTT AY593810
55 C1 Noville/65 Switzerland, 1965 2 PI, BHK-21 AY593804
56 C1 Oberbayern/60 Germany, 1960 BHK-21 AY593805
57 C3 Indaial/71 Brazil, 1971 2 BHK-21 AY593806
58 C3 Resende/55 Brazil, 1955 1 LK AY593807
59 C4 Tierra del Fuego/66 Tierra del Fuego, Argentina, 1966 1 LK AY593808
60 C5 Argentina/69 Argentina, 1969 5 BHK-21, 5 GP AY593809
61 O Rey Iran/66 Iran, 1966 BTT, BK, 1 LK AY593834
62 O Uruguay/63 Uruguay, 1963 BK, 2 LK AY593837
63 O UK 2001 United Kingdom, 2001 BVF AY593836
64 O UK2001-ED Plum Island, 2002 1 BHK-21 AY593831
65 O UK2001-FB Plum Island, 2002 2 BHK-21 AY593832
66 O1 Argentina/65 Argentina, 1965 2 BTT, 1 LK AY593814
67 O1 BFS18/67 United Kingdom 1 LK AY593815
Continued on facing page
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TABLE 1—Continued
Sequence
no.c Isolate name
a Country, year of isolation Passage historyb Accessionno.
68 O1 BFS46/67 United Kingdom 2 BHK-21 AY593816
69 O1 Brugge Belgium, 1973 1 LK AY593817
70 O1 Campos/58 Brazil, 1958 1 BTT AY593818
71 O1 Campos/94 Plum Island BHK-21 AY593819
72 O1 Canefa/64 Argentina, 1964 2 BTT AY593820
73 O1 Caseros/67 Argentina, 1967 4 BTT AY593821
74 O1 M11 Unknown, 1953 BTT AY593822
75 O1 Manisa/69 Turkey, 1969 BVF AY593823
76 O1 SKR/00 S. Korea, 2000 Swine epithelium AY593824
77 O1 Vallee/39 Pirbright, 1953 Bovine epithelium AY593825
78 O10 Philippines Philippines/58 1 LK AY593811
79 O10 Philippines 2/58 Philippines/58 BTY, BK, BOV AY593812
80 O11 Indonesia/62 Indonesia, 1962 BTT, 2 LK AY593813
81 O2 Brescia/47 Italy, 1947 1 LK AY593826
82 O3 Venezuela/71 Venezuela, 1971 BTT, 1 LK AY593827
83 O5 India/62 India, 1962 1 BK, 1 BTT AY593828
84 O6 Pirbright/65 United Kingdom /65 4 GP AY593829
85 O7 Poland/59 Poland, 1959 1 LK AY593830
86 O Taiwan/97 Taiwan, 1997 Swine epithelium AY593835
87 O Penghu/99 Taiwan, 1999 Swine epithelium AY593833
88 SAT 1 BOT 1/68 Botswana (BEC), 1968 3 BTY, 5 BHK-21 AY593845
89 SAT 1 Rhod5/66 Rhodesia, 1966 1 BTT AY593846
90 SAT 1/1 BEC Botswana (BEC), 1970 2 LK AY593838
91 SAT 1/20 RV 11/37 Pirbright, WRL, 1970 3 IBRS-2 AY593839
92 SAT 1/3 SWA1/49 Unknown, 1970 4 IBRS-2 AY593840
93 SAT 1/4 SR2/58 Rhodesia, 1970 3 IBRS-2 AY593841
94 SAT 1/5 SA/61 Unknown, 1972 3 IBRS-2 AY593842
95 SAT 1/6 SWA40/61 Unknown, 1970 3 IBRS-2 AY593843
96 SAT 1/7 ISRL 4/62 Israel, 1962 3 IBRS-2 AY593844
97 SAT 2/1 Rhod/48 Rhodesia, 1948 3 IBRS-2 AY593847
98 SAT 2/2 106/67 Unknown, 1970 2 IBRS-2 AY593848
99 SAT 2/3 Kenya 11/60 Kenya, 1960 3 IBRS-2 AY593849
100 SAT 3/2 SA57/59 Unknown, 1969 1 LK AY593850
101 SAT 3/3 BEC20/61 Botswana (BEC), 1961 2 LK AY593851
102 SAT 3/3 Kenya 11/60 Kenya, 1960 4 IBRS-2 AY593852
103 SAT 3/4 BEC 1/65 Botswana (BEC), 1965 1 LK AY593853
104 O/JPN/2000 Japan BEF, 4 BK AB079061
105 O strain Chu-Pei Taiwan Swine AF026168
106 OTau-YuanTW97 Taiwan Unknown AF154271
107 O1 Geshure Israel Unknown AF189157
108 O1 Yunlin Taiwan Swine AF308157
109 O/SK 2000 South Korea Unknown AF377945
AY312586
O/SK 2002 South Korea Unknown AY312588
110 O Tibet /1/99 China Unknown AF506822
111 O Akesu/58 China BOV AF511039
112 SAT 2 ZIM/7/83 Zimbabwe, clone Vaccine strain, cloned AF540910
113 A12-strain 119 United Kingdom Tissue culture, cloned M10975
114 Asia 1 IND 63/72 India, vaccine Vaccine strain, unknown AY304994
115 A22/550 Azerbaijan 65 USSR Unknown X74812
116 O-HKN/2002 China Unknown AY317098
117 O strain OMIII Attenuated from strain Akesu/58 Unknown AY359854
118 Asia1 YNBS/58 China Unknown AY390432
119 C rp99 C-S8c1 derivative Persistently infected BHK-21 cells, passage 99 FAN133358
120 C rp146 C-S8c1 derivative Persistently infected BHK-21 cells, passage 146 FAN133359
121 C-s8c1 Spain (Olot) BHK-21 FDI133357
122 SAT 2 KEN/3/57 Kenya Unknown FDI251473
123 O1Campos Brazil Tissue culture, cloned FDI320488
124 C3Arg85 Argentina BHK-21 FMV7347
125 C3Arg85 Rb-15 C3Arg85 derivative Partially resistant BHK-Rb cells FMV7572
126 TAW/2/99 TC Taiwan BEF, 3 BHK-21, 1 BTY, 2 BHK-21 AJ539136
127 TAW/2/99 BOV Taiwan BEF, 3BHK-21, 1BTY, 2BHK-21, 1 BOV, 2 swine, 1 BOV AJ539137
128 Tibet/CHA/99 China 1 BOV, 3 BHK-21 AJ539138
129 O/SK 2000 South Korea BOV,1 BHK-21 AJ539139
130 SAR/19/2000 South Africa BOV, 2 PK, 1 IBRS-2, 1 BHK-21 AJ539140
131 UKG/35/2001 United Kingdom 2 swine AJ539141
132 A10-61 Argentina Unknown, cloned PIFMDV1
133 O1-Kaufbeuren/66 Germany BHK-21, cloned PIFMDV
a , RNA was extracted directly from tissue or vesicular fluid.
b BHK, BHK21 baby hamster kidney cells; LK, PK, and BK, lamb, porcine, and bovine kidney cells, respectively; BTY, bovine thyroid cells; IBRS-2, porcine kidney epithelial
cell line; ET, epithelial tissue; BTT, bovine tongue tissue; GP, guinea pig vesicular fluid; BOV, bovine; BVF, bovine vesicular fluid; BEF, bovine esophageal fluid.
c Sequence numbers 104 to 133 are FMDV sequences from GenBank.
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dancy rate ranging from 13 to 48 and averaged 28 sequence events per nucleo-
tide.
Direct DNA sequencing of amplicons derived from a given FMDV isolate
yielded a master sequence representing the most probable nt for each position of
the sequence. This approach prevented analyses of minor sequence variants,
polymerase misincorporation errors, and sequencing ambiguities through multi-
ple independent cDNA synthesis, PCR amplification, and direct sequencing
events. Due to the quasispecies nature of FMDV populations, polymorphisms
were detected at some nt positions. Nevertheless, all positions could be unam-
biguously assigned to a single nt due to the high degree of redundancy generated
by the sequencing strategy. The following sequence ambiguity code was used: K
(T/G), M (A/C), R (A/G), S (C/G), W (A/T), Y (C/T), B (C/T/G), D (A/T/G), H
(A/C/T), V (A/C/G), and N (A/C/G/T).
Sequence analysis. Bases were called from chromatogram traces produced
with Phred (25), which also produced a quality file containing a predicted prob-
ability of error at each base position. Viral sequences were assembled with the
Phrap (http://www.phrap.org) and CAP3 assemblers (43). Gap closure was per-
formed as described previously (3). Multiple sequence alignments were per-
formed with the ClustalW (1.7) and Dialign (2.2) computer programs (73, 107).
The positions of 5 UTR sequences presented in Results refer to the consensus
sequence generated by ClustalW alignment of this region for the 103 isolates,
with some manual editing. Nucleotide substitution analysis was carried out by use
of the DISTREE (1.2) (103), DNArates (1.1) (105), ALISTAT (16), and
PRETTY (GCG 10 software package [16]) programs. Analyses of codons and
synonymous/nonsynonymous (syn/nonsyn) substitution ratios were calculated by
using SNAP (77), CodonW (http://www.molbiol.ox.ac.uk/cu/), and codeml
(PAML3.14 package), which was also used for statistical evaluations of hetero-
geneous selection pressures at amino acid sites (116). For protein analysis, the
PRETTY program was used. Searches for motifs and/or signal sequences were
performed with the MOTIFS (GCG package), HMM (58), pfscan (http://ww-
w.isrec.isb-sib.ch/ftp-server/pftools/pft2.2/pft2.2.tar.Z), and Blocks (36) pro-
grams of the PROSITE, Pfam, and Blocks databases. Transmembrane protein
segment predictions were performed by using Memsat (50), Tmpred (41), Top-
pred (114), Psort (76), and Saps (11). Secondary structure predictions were
performed for proteins by using GOR secondary structure prediction (29) and
Pratt (48, 49) and for RNAs by using mfold (46, 117), rnafold (40), and Squiggles
(83). Pseudoknot analysis was conducted with pknots (96).
Phylogenetic analysis was performed on aligned genomic and subgenomic
regions of FMDV by utilizing the neighbor-joining and split decomposition
methods as implemented in the Phylo_win (28) and/or SplitsTree 4.0 (http:
//www-ab.informatik.uni-tuebingen.de/software/jsplits/welcome_en.html)
(44) software package and by utilizing maximum likelihood as implemented
in Puzzle (104) and dnaml in the Phylip package (http://evolution.genetics
.washington.edu/phylip.html) (27). Individual protein-coding regions were used
to screen for incongruent tree topologies suggestive of genomic recombination,
and split decomposition analysis (7) of genomic and subgenomic regions was
utilized to graphically screen for reticulated branching patterns which were also
suggestive of recombination. Similarity plots and bootscanning analysis (100),
which compare a given query sequence to several reference sequences via incre-
mental sliding sequence windows to yield corrected similarity values and boot-
strap resampling frequencies, respectively, were performed as implemented in
the SimPlot, v. 2.5, package (63), utilizing default settings and a window size of
400 nt. As a further test for potential recombination, Sawyer’s run test (102), as
implemented in GENECONV, v. 1.81 (http://www.math.wustl.edu/sawyer),
was used on Dialign-aligned FMDV polyprotein-encoding regions, using default
settings.
Nucleotide sequence accession numbers. The GenBank accession numbers for
the genome sequences of FMDV isolates sequenced for this study are listed in
Table 1.
RESULTS AND DISCUSSION
With the exception of the poly(C) tract, full-length genomic
sequences from 103 FMDV isolates representing all serotypes,
including isolates from serotypes not previously fully se-
quenced (SAT1 and SAT3), were obtained and analyzed.
Given that the structure and dynamics of FMDV populations
in nature are complex and the relatively small number of SAT2
and SAT3 genomes presented here, it is possible that addi-
tional sequence data from field isolates will alter the status of
residues and nucleotides presented below as invariant.
FMDV genomes ranged from 8,046 to 8,215 nt, consistent
with previously reported genome lengths (86, 108). Although
small insertions/deletions were observed in the coding region
affecting Lpro, 1B, 1C, 1D, and 3A, most variability in genome
size was due to insertions/deletions in the UTRs.
5 UTR. The approximately 1,300-base 5 UTR plays impor-
tant roles in FMDV replication. However, the specific contri-
bution of S fragment, poly(C) tract, and L fragment
pseudoknots to FMDV biology is unknown. The cardiovirus
poly(C) tract has been shown to affect virulence (23), while
shortening of the FMDV poly(C) tract affected virus growth in
vitro but not virulence in a suckling mouse model (95). The cre
is essential for picornaviral replication and contains a con-
served AAACA motif which in poliovirus functions as a tem-
plate for 3Dpol-mediated uridylylation of 3B (75). Mutation of
the FMDV cre stem region reduced virus RNA replication
(68). The approximately 500-nt FMDV IRES, which is respon-
sible for cap-independent polyprotein translation (60), is pre-
dicted to contain four structural domains (Fig. 1D, panel II,
domains 2 to 5) that interact with cellular factors involved in
host translation initiation (94). Domain 2 binds the polypyri-
midine tract-binding protein at a UUUC motif. Domain 3
contains at least three loop structures that are conserved in all
picornaviruses, including a GNRA motif essential for the
maintenance of the IRES tertiary structure and potentially
involved in long-range RNA-RNA interactions. The Y-shaped
domain 4 and domain 5 interact with the host translational
factors eIF4B and eIF4G (65, 99). A 22-nt spacer for ribosomal
recognition separates the IRES from the first of two polypro-
tein start codons, and an additional 84 nt separates the first
start codon from the second. Picornavirus utilization of the
second start codon seems to be affected by its adjacent se-
quence and by sequences in the IRES (82). Unlike poliovirus,
FMDV utilizes the second start codon twice as often as the first
(66).
The analysis in this study of 5 UTRs from 103 FMDV
isolates showed that only 12% and 33% of nt were invariant in
the 5 UTR S and L fragments, respectively (Fig. 1B and C;
Table 2). In pairwise comparisons, however, FMDV isolates
averaged 80% and 85% nt identity for the S and L fragments,
respectively, indicating a high degree of conservation between
isolates. This suggests that although the FMDV 5 UTR can
tolerate changes at most positions, selective pressures clearly
favor overall conservation, likely for the maintenance of a
functional secondary structure. Relatively high rates of substi-
tution (10) in the 5 UTR L fragment were observed at
positions 513, 558, 615, 684, 696, and 1144 (Fig. 1B).
5 UTR S fragment. S fragment lengths averaged 322 and
373 nt for SAT and Euroasiatic isolates, respectively, and
spanned positions 1 to 393 in the 5 UTR alignment (Fig. 1B).
SAT viruses contained insertions/deletions of 1 to 3 nt, with
most occurring at positions 120 to 160 and 200 to 300, includ-
ing SAT-specific nt present at positions 38, 39, 67, 95, 250, 350,
366, and 375. Euroasiatic isolates contained insertions/dele-
tions of 1 to 5 nt in length (with the exception of isolates C
Waldman strain 149, A Canefa 1/61, and A25 Argentina/59,
which contained a 76-nt deletion between positions 153 and
228) and included Euroasiatic-specific nt present at positions
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86, 123, 124, 144, 145, 155, 156, 157, 174, 181 to 191, 197 to 219,
240, 256, 277, 292 to 294, 300 to 306, and 324 (Table 3).
Notably, SAT1/7 Isrl 4/62 and SAT2-3 Kenya 11/60 appeared
to have the most complete S fragment sequences of those
sampled, lacking both SAT and Euroasiatic-specific deletions,
and contained nt at positions 142, 143, 239, 290, 291, and 307
which were absent from other viruses.
Although the overall nt substitution rates in the S fragment
were low, specific regions of variability were observed, and only
19 nt were invariant, excluding the regions used to prime am-
plification (Fig. 1C and D). S fragment sequences generally
grouped into SAT and Euroasiatic lineages, which averaged
only 50% nt identity with each other; however, little or no
correlation with other serotypic groupings was observed (data
not shown). Notably, several isolates of disparate serotypes
contained very similar S fragment sequences, including the C
Waldman strain 149 and A12 Valle strain 119 S fragments,
which shared 98% nt identity.
In most cases, secondary structure analyses of S fragments
predicted a single stem-loop structure similar to that previously
proposed (12, 24). However, the S fragment sequences of 16%
of the isolates folded into alternative structures within similar
free energy levels (e.g., strains A22 Turkey/65, A24 Argentina
65, and Asia 1 Leb 83) (data not shown).
5 UTR L fragment. The 5 UTR region of the L fragment
ranged from 604 to 751 nt long. Remarkably, apparently un-
related virus isolates contained identical deletions in the L
fragment (Table 3). SAT and Euroasiatic-specific L fragment
insertions/deletions were identified, as were isolate-specific in-
sertions/deletions, including an 18-nt insertion located 28 nt
downstream of the poly(C) tract in strain A5 Westerwald/51.
The pseudoknot region between positions 403 and 600 was
highly tolerant to changes, with no invariant nt located within
the first 200 positions and insertions/deletions tolerated at each
position (Fig. 1C). Previously undescribed invariant nt and
motifs located between the pseudoknot region and the IRES
included AGAAWYGGGACGU (positions 617 to 629),
GCRCACGWAACGCGC (positions 632 to 646), and
ACAAAC (positions 668 to 673) within the cre.
FMDV IRES sequences (positions 640 to 1151) showed 70
to 100% nt identity in pairwise comparisons, 47% invariant nt,
and numerous invariant motifs in the predicted secondary
structure domains (Fig. 1C and D). Domain 2 contained the
polypyrimidine tract-binding protein motif UUUC and three
previously undescribed motifs at the base, bulge (invariant
GGUCUWGAG motif), and apex regions of the stem-loop.
Domain 3 contained GYRA (corresponding to the conserved
picornaviral GNRA motif) and CRAAA (except in isolates
O1Argentina/65 and OAkesu/58) motifs in loops A and B,
respectively. While the picornavirus domain 3 loop D motif
ACCC was present in 99/103 FMDV isolates, the loop 3C
motif ACAC was not conserved in FMDV. Domain 3 also
contained novel highly conserved motifs, including the UCGU
MGCGGAGCA (positions 823 to 835) motif and GRUACU
GGUA and GRGACUGGUA motifs (positions 965 to 974),
specific for Euroasiatic and SAT serotypes, respectively, and
CUGGWGRCAGGCUAAGGAUGCCCU (positions 983 to
1006), predicted to form a prominent bulge at the base of the
stem (Fig. 1C and D). Domain 4 was highly conserved, with
two novel invariant motifs (GAUCUGAG [positions 1039 to
1046] and UUAAAAG [positions 1080 to 1087]) predicted to
form prominent bulges in the secondary structure. In domain
5, 19 of the 21 nt were invariant (Fig. 1C and D). The conser-
vation of these motifs suggests biological significance. Notably,
the 22-nt region between the IRES and the first AUG was
highly variable, possibly underlying FMDV’s preferential use
of the second start codon (9, 66). In summary, the FMDV 5
UTR, although tolerant for nt substitutions and insertions/
deletions, showed significant conservation, especially in the
IRES, where novel sequence motifs were identified.
Polyprotein region. (i) Nucleotide sequence and codon anal-
ysis. The nucleotide variability for the 103 FMDV polyprotein
(ORF) and individual protein regions is summarized in Table
2. Overall, 46% of all nt were invariant, with 73% nt identity
between the least similar pair of sequences. An average tran-
sition/transversion (Ts/Tv) rate of 2.4 and syn/nonsyn substitu-
tion ratio of 2.1 were observed. As expected, the region en-
coding 1D was the most variable, exhibiting the lowest
percentage of invariant nt (21%), Ts/Tv rate (1.55), and syn/
nonsyn ratio (1.03) of all regions. In fact, excluding the highly
conserved 1A (VP4) protein, regions encoding structural pro-
teins had significantly lower Ts/Tv rates, nonsyn substitutions/
site, and syn/nonsyn ratios than the rest of the genome. Al-
though the substitution rates given here are averages for each
protein-coding region, specific regions or residues within each
protein were observed to contain higher or lower substitution
rates (Fig. 2B and C).
In general, regions encoding FMDV nonstructural proteins
were highly conserved between isolates, exhibiting higher per-
TABLE 2. FMDV genome variabilitya
UTR or
genome
region
No. of
nt positions
aligned
No. of
invariant
nt
%
Invariant
nt
Ts/Tv
rate
(%)
Average
pairwise
identity
(%)
Minimum
pairwise
identity
(%)
5 UTR 1,150 303 26 2.89 83 64
S-UTR 393 48 12 3.93 80 51
L-UTR 757 255 33 2.63 85 70
3 UTR 161 15 9 3.93 82 63
ORF 7,076 3,287 46 2.44 84 73
Lpro 606 227 37 3.23 80 61
1A 255 143 56 2.53 84 73
1B 660 243 37 1.75 75 62
1C 675 235 35 1.84 75 58
1D 693 147 21 1.55 68 48
2A 48 23 48 2.64 89 73
2B 462 282 61 6.67 91 81
2C 953 527 55 5.14 89 78
3A 459 160 35 3.75 85 68
3B 216 96 44 5.51 89 69
3C 639 380 59 4.12 89 77
3D 1,410 824 58 5.53 91 83
a Estimates were based on ClustalW (UTR data) or Dialign (ORF data)
alignments of the 103 FMDV isolates examined. The number of invariant nt for
each genomic region relative to the total number of positions was used to
estimate the percentage of invariant nt. The ratio of transitions to transversions
(Ts/Tv) was obtained by using Distree and Kimura 2 parameter correction with
gamma distributions. ALISTAT was used to obtain the average % pairwise
identity and the minimum pairwise identity. The 5 UTR includes the S and L
fragments 5 of the first AUG. The S-UTR includes nt from position 1 to the
poly(C) tract. The L-UTR includes nt from the end of the poly(C) tract to the
first AUG. The 3 UTR includes nt from the polyprotein stop codon to the
poly(A) tail.
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centages of invariant residues, higher Ts/Tv rates and syn/
nonsyn substitution ratios, and lower overall numbers of non-
syn changes/site (Table 2; Fig. 2C). The most conserved
FMDV regions were those encoding 2B and 3C, which exhib-
ited the highest percentage of invariant nt (61% and 59%,
respectively) and amino acids (76%) in the genome. Notably,
the nonstructural proteins Lpro, 3A, and 3B exhibited variabil-
ity comparable to that of the structural proteins 1B, 1C, and 1D
(Table 4), suggesting that these proteins are subjected to se-
lective pressures distinct from those on the other nonstructural
proteins. A comparison of CODEML  rates between different
substitution models further indicated that four of these pro-
teins (Lpro, 1D, 3A, and 3B) may indeed undergo diversifying
selection (Table 4) (116). Notably, this was observed for rela-
tively few codons (1.5% to 7.6%), with fewer highly significant
ones (P 0.9) tending to cluster within each protein (positions
19, 20, 22, 23, and 82 in Lpro; positions 45, 48, 142, 143, 144,
and 146 in 1D; positions 44, 132, 135, 136, and 144 in 3A;
positions 4 and 11 in 3B1; and positions 17, 18, and 19 in 3B2).
Interestingly, the variable capsid proteins 1B and 1C did not
appear in this analysis to undergo diversifying selection (Table
4).
(ii) Amino acid sequence analysis. Fifty-eight percent of all
amino acids (aa) were invariant among the FMDV isolates
analyzed here, with the percentage of amino acid conservation
for each viral protein correlating with nt conservation in the
corresponding genomic region (Fig. 3; Tables 2 and 4). Posi-
tions at putative protein cleavage sites showed various degrees
of sequence conservation, with Euroasiatic lineages being
more conserved than SATs. Residues at the 1A/1B, 2A/2B,
2B/2C, 2C/3A, and 3B/3C cleavage sites exhibited high degrees
of conservation (Table 5).
Leader proteinase. FMDV Lpro is expressed as long (Lab)
and short (Lb) isoforms that result from alternative usage of
either the first or second start codon, respectively, with the
sequence between the two AUGs predicted to form a stable
hairpin structure crucial to IRES activity (39, 66). Lpro iso-
forms have indistinguishable activities and specificities and
have been proposed to play a role in virulence that may involve
the regulation of host interferon responses (89).
TABLE 3. Selected FMDV 5 UTR insertions/deletions
Isolate or fragmenta
nt positions
Isolate or fragmenta
nt positions
Ins Dels Ins Dels
S
A1 Bayern/Bavaria 80–82
A3 Mecklenburg/68 80–82
A Canefa 1/61 114
A25 Argentina/59 114
Asia 1/1 PAK/54 114
O11 Indonesia/62 114
SAT 1/7 ISRL 4/62 142, 143
SAT 2/3 Kenya 11/60 142, 143
C Waldman strain 149 153–228
A25 Argentina/59 153–228
A Canefa 1/61 153–228
A24 270
O1 Argentina 270
SAT 1/7 ISRL 4/62 290, 291
SAT 2/3 Kenya 11/60 290, 291
A Argentina/01 Areco 290–293
A ARGp55/01 290–293
A ARGp64/01 290–293
A General Lopez/01 290–293
A Trenquelauquen/01 290–293
A Uruguay/01 290–293
A Uruguay/98 290–293
O UK 2001 292
O UK 2001-ED 292
O UK 2001-FB 292
O1 SKR/00 292
A22 Azerbaijan 320
A22 Iraq24/64 320
A22 Iraq26/64 320
A22 Turkey/65 320
A28 Turkey/72 320
A22 Turkey/65 364–366
A28 Turkey/72 364–366
L
A28 Turkey/72 418–478
O1 Vallee/39 418–478
a , isolates from which RNA was extracted directly from tissue or vesicular fluid.
O5 India/62 418–478
O Akesu/58 418–478
O Akesu/58 vaccine 418–501
C1 Noville/65 418–478
C1 Oberbayern/60 418–478
C-s8c1 Spain 418–478
C-Perst.inf.BHKp99 418–478
C-Perst.inf.BHKp146 418–478
SAT 1/7 ISRL 4/62 418–487
A24 Cruzeiro/55 427–487
A21 Kenya/64 427–487
A20 USSR 1/64 427–487
O11 Indonesia/62 427–487
SAT 2/3 Kenya 11/60 427–487
SAT 1/20 RV 11/37 427–487
SAT 1 Rhod5/66 427–487
SAT 2/1 Rhod/48 427–487
SAT 2/2 106/67 427–487
SAT 3-4 BEC 1/65 427–487
A5 Westerwald/51 427–443
O Penghu/99 460–502
O Yunlin Tw97 460–502
O HKN/2002 460–502
O Taiwan/97 460–502
A26 Argentina/66 419–523
A16 Belem/59 419–523
O11 Indonesia/62 523–546
Asia1-IND 63/72 554–591
A3 Mecklenburg/68 554–591
A4 Spain 554–591
A2 Spain/69 554–591
A4 WG/72 554–591
A1 Bayern/Bavaria 554–591
A10 Holland/42 554–591
O1 M11 554–591
O2 Brescia/47 554–591
O3 Venezuela/71 554–591
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FIG. 2. FMDV coding region variability. (A) Schematic diagram of FMDV polyprotein coding region showing the positions of, from top to
bottom, protein-encoding regions (open boxes), cleavage intermediates, and mature proteins (lines). (B) Graphic representation of rates of nt
substitution per site as calculated with DNArates software. (C) Graphic representation of nonsynonymous substitutions per site as calculated with
SNAP software.
TABLE 4. FMDV genome variability in encoded amino acid sequencesa
Genome
region
No. of
aa positions
aligned
No. of
invariant aa
% Invariant
aa
SNAP result CODEML result
Syn Nonsyn Syn/nonsyn  t PS
ORF 2,360 1,363 58 756 362 2.08 ND ND ND
Lpro 202 89 44 70 45 1.55 0.27 20.8 Y
1A 84 68 81 33 5 6.6 0.01 22.5 N
1B 221 103 47 100 63 1.6 0.06 34.9 N
1C 225 87 39 99 63 1.6 0.08 32.9 N
1D 232 56 24 102 99 1.03 0.16 35.8 Y
2A 17 11 65 5 0.52 9.6 ND ND ND
2B 153 117 76 35 7 5 0.06 8 N
2C 318 228 72 83 18 4.6 0.06 10.5 N
3A 153 57 37 44 21 2.1 0.16 12.7 Y
3B 72 36 50 17 6 2.8 0.33 8.2 Y
3C 213 163 76 55 14 3.9 0.04 11.3 N
3D 471 348 74 113 20 5.6 0.06 8.4 N
a The synonymous/nonsynonymous (syn/nonsyn) substitutions were estimated by use of the Nei and Gojobori algorithm as implemented in SNAP. Estimates for
diversifying positive selection were obtained by using codeml. , nonsyn/syn ratio averaged over sites (dN/dS); t, maximum-likelihood tree length measured by the
number of nt substitutions along the tree per codon; PS, positive selection; Y, yes; N, no; ND, not done.
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Lpro lacked insertions/deletions, with the exception of two ad-
ditional aa in Euroasiatic lineages (positions 22 and 23). Each
methionine start codon was invariant, indicating that both Lpro
isoforms are significant for aspects of FMDV biology. Consistent
with the previously described hypervariability in the region
flanked by the two AUGs, only one residue (C6) was invariant in
this region (113). Only 44% of the residues in Lb were invariant,
making it much less conserved than was previously reported (30).
Although substitutions were concentrated in terminal regions of
Lpro, the predicted secondary structure in these regions remained
relatively unaltered (data not shown).
A detailed analysis of the Lpro/1A junction resulted in a
more ambiguous cleavage motif than was previously described
(Table 5) (113). Only GAGXS at the 1A N terminus and the
previously described basic residue (K/R) required for cleavage
at the Lpro C terminus were invariant. Residues required for
Lpro catalytic activity (C52, H149, and D165) (32, 59), sug-
gested to be involved in Lpro autocatalysis (E77) (89), and
important for eIF4G cleavage (H110 and H139) (90) were
invariant, except for an H110D substitution in all SAT viruses,
an E77Q substitution in O6 Pirbright/65, and an E77K substi-
tution in A Phillipines/75 (Table 6). The present FMDV anal-
ysis revealed that only 43 of the 65 residues previously identi-
fied as conserved between FMDV O1 Kaufbeuren/66 Lpro and
the aphthovirus equine rhinitis A virus Lpro were invariant,
with 35 of the 43 residues concentrated in three distinct regions
(positions 44 to 63, 95 to 110, and 133 to 185) (38) (Table 6).
Additional, previously undescribed invariant FMDV Lpro mo-
tifs are shown in Table 6.
These data indicate that despite a relatively low overall Lpro
aa sequence conservation among the FMDV isolates examined
here, functional elements such as the catalytic and cleavage
sites and additional, previously undescribed motifs are invari-
ant. The variability observed at the Lpro N and C termini may
affect specific virus-host interactions, including ribosomal rec-
ognition of alternative start codons.
Structural proteins. FMDV structural proteins are involved
in capsid assembly and stability, virus binding to target cells,
and antigenic specificity, influencing significant aspects of virus
infection and immunity (45). The high level of variability in
FMDV external capsid proteins observed here likely reflects
the selective pressures on them.
FIG. 3. FMDV invariant amino acids (single letter code). The consensus sequence is based on the comparison of 103 FMDV isolates conducted
for this study, with the exception of the 1D region, which also included all 1D sequences available in GenBank (release 141).
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(i) 1A (VP4). 1A was the most conserved FMDV protein,
with 81% of the aa being invariant (Fig. 3; Table 4), including
the N-terminal myristylation site and a previously identified
heterotypic swine and bovine T-cell epitope (1A positions 20 to
35) (10). Interestingly, the Q73 residue in the SAT viruses
distinguishes them from Euroasiatic lineages. Residues poten-
tially specific for SAT2 and SAT3 (I76) and for SAT1 (V80)
were also identified.
(ii) 1B (VP2). 1B, a protein of 218 or 219 aa, plays a critical
role in virion structural stability and maturation (14). N-termi-
nal regions of 1B contain previously undescribed motifs. For
example, DKKTEETTLLEDRILTTRNGHT(T/I)STTQSSVG
and DKKTEETT(L/H)LEDRI(L/M/V)TT(S/R)H(G/N)TTTST
TQSSVG are conserved among Euroasiatic and SAT virus iso-
lates, respectively. Three previously identified T-cell epitopes (po-
sitions 48 to 68, 114 to 132, and 179 to 187) were conserved (88).
Notably, only the N-terminal half of each epitope was invariant,
while their C-terminal regions were highly variable.
(iii) 1C (VP3). 1C, a protein of 219 to 221 aa, contains
important conformational neutralizing epitopes and makes sig-
nificant contributions to capsid stability (62). Among the
FMDV isolates examined here, 1C was highly variable, with
only 39% of the aa being invariant. Most amino acid substitu-
tions were concentrated in four regions (positions 55 to 88, 130
to 140, 176 to 186, and 196 to 208), with insertions/deletions
present in the first two regions and a previously described
T-cell epitope present in the second region (88). The 1B/1C
cleavage site was nearly invariant in Euroasiatic lineages but
much less conserved among SAT isolates (Table 5).
(iv) 1D (VP1). 1D is the most studied FMDV protein due to
its significance for virus attachment and entry, protective im-
munity, and serotype specificity (45). 1D ranges in size from
217 to 221 aa, with insertions/deletions contained in regions
140-150 and 166-170. Overall, only 26% of the 1D residues are
invariant. The invariant residues and motifs are shown in Fig.
3. Given the available data and the proposed significance of the
conserved RGD motif for virus reception and pathogenesis
(71, 72), it is notable that complete integrin-binding RGD
motifs were lacking in 9 of the 103 FMDV isolates examined
here (GGD in C Waldman strain 149 and C4 Tierra del Fuego/
66, TGD in C5 Argentina/69, RGE in Asia1/2 Isrl 3/63 and A21
Kenya/64, RDD in A25 Argentina/59 and A Canefa 1/61, HGD
in Asia1/3 Kimrom, and PGD in A27 Colombia/67) and in
additional sequences present in GenBank (RGN in Asia1 Pak/
1/54 and O/Syria/1/87, RSG in A A/IND/110/99, RGE in O
KEN/5/95, KGD in O PAK/1/94 and O/IRQ/26/2000, SGD in
O Akesu/58, and IGD in O3/Venezuela/51), with substitutions
tolerable at any one of the three residues.
Exposure of the 1D N terminus, a region which includes a
10-aa motif which is conserved in several other picornaviruses,
is critical for poliovirus entry into the cell (13). The FMDV 1D
sequences studied here lack this N-terminal motif, suggesting
that some aspects of viral entry may differ from those of other
picornaviruses.
TABLE 6. Amino acid conservation in FMDV and ERAV Lpro
Position no.a 1 6 30, 31 37 40 42 44–47 51–55 58–63 66, 67 73 75, 76 80
FMDVb M C ME G K F SRPN NCWLN QLFRY EP Y SP T
FMDV/ERAVc M NCWLN QL T
Position no. 87 91 93 95 98–102 104 106 108–110 112 114, 115 117, 118 121–124 126 130
FMDV L T L L GGPPA V W IK(H/D) L TG GT RPSE C G
FMDV/ERAV T L G PP V GT P G
Position no. 133–143 145, 146 149–153 156 159, 160 162 164–166 169–173 175 178, 179 183–185 187–189
FMDV M(C/T)LADFHAGIF KG HAVFA T GW A DDE YPWTP P VL VPYD EP
FMDV/ERAV L DF A K HAVF T GW DD YP TP VL PYD
a Numbers indicate Lpro amino acid positions from the first polyprotein AUG of Dialign-aligned FMDV polyproteins.
b Invariant Lpro residues among 133 FMDV isolates. The proteolytic active sites C52 and H149 are shown in bold.
c Invariant Lpro residues between FMDV and ERAV sequences (38).
TABLE 7. FMDV 3B (VPg) variability
Serotype Sequencea
3B1 G P Y A* G P L E R Q K* P L K V R A K L P Q Q E
T23 M3 Q14 R2 L14 K38 T5 E4 P1 R6 A14
S2 V1 R19 V2 R1 F1 K4 H5
I1 R1
3B2 G P Y A G P M E R Q K P L K V K A* K* A* P V V K E
V3 R1 L23 D1 K10 Q18 R3 L15 R4 V29 R21 L15 S1 A16 R1
T4 T3 I4
E1 N/P/V1
3B3 G P Y E G P V K K P V A L K V K A K N L I V T E
D1 M1 R1 R1 A1 L1 R1 T2 R1 A15 P15
M3
a The most frequent amino acid for each position is shown in the top row for each serotype; alternative amino acids and the number of isolates with that particular
residue (subscripts) are listed below. SAT serotype-specific residues are shown in italics. Asterisks indicate positions predicted to undergo diversifying selection by
codeml analysis.
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Structural implications of capsid protein amino acid con-
servation. Picornaviral 1A is cleaved from the 1AB (VP0)
precursor by unknown mechanisms, and this cleavage is re-
quired for virion maturation and infectivity (6, 74). During
poliovirus entry into host cells, 1A is involved in receptor-
mediated capsid conformational changes resulting in mem-
brane ion channel formation and the release of viral RNA into
the cytoplasm (reviewed in reference 42). Several FMDV res-
idues which are known or suspected to affect 1AB cleavage
based on their homology to other picornaviral 1ABs were
identified in the FMDV isolates examined here. Notably, a
number of these residues were located in previously unidenti-
fied invariant sequence motifs, suggesting that the critical func-
tion of these residues may be contextual. Specifically, these
included 1B residues H145, P144, and L83 and 1C residues
G39, F41 (replaced by Y in three isolates), and A50, which is
included in the conserved motif LDVAEACPT (positions 45
to 53) (8). Additional residues contributing to the 1AB cleav-
age pocket include 1D P204, contained in the motif
RMKRAE(T/L)YCPR (positions 195 to 205), and 1B V32 (I
in SAT2 viruses), T33, and Y36, included in the motif TTST
TQSSVG(V/I)T(Y/F)GY (positions 22 to 36). C-terminal to
this last motif lies a putative serotype sequence signature (po-
sitions 36 to 47) confirmed for 173 available 1B sequences
(YSTXEDHXXGPN in A viruses, YXTXEDFVXGPN in O
viruses, YATXEDXXGPN in C viruses, YXVXEDAVSGPN
in Asia1 viruses, YAXXDXFLPGPN in SAT1 viruses, YADX
DSFRXGPN in SAT2 viruses, and YXSADRFLPGPN in
SAT3 viruses) and the motif GPNT(S/N)GLEXRVxQA
ER(F/Y)(F/Y)K (positions 45 to 63), which is present in all
FMDV isolates examined here.
An H-rich region at the 1B/1C interphase is proposed to
mediate 1B-1C hydrogen bonding and is likely involved in
virion sensitivity to acid, a characteristic with implications for
virus stability and transmission (2). 1B residues H21 (position
19 in SAT viruses), H145, H157, and H174 were invariant in all
FMDV isolates studied here, while H87P and H168Y substi-
tutions were present in serotype C and Euroasiatic viruses,
respectively. In addition, 1C contained five invariant H resi-
dues, at positions 86 (84 in SAT viruses), 109, 146, 149, and 198
(196 in SAT viruses).
The N termini of five 1C molecules make up the  annulus
at the axis of virion fivefold symmetry, thus contributing to
capsid stability (1). The 53 N-terminal residues of 1C, includ-
ing P4, which is possibly involved in binding to the 3Cpro
substrate-binding site, and C7, a residue that is invariant in
Euroasiatic isolates and involved in disulfide bonding between
1C N termini, were invariant within serotypes (1). However, all
SAT viruses demonstrated an unexpected nonconservative
C7V substitution, suggesting that SAT virus capsids may ex-
hibit distinct physical properties.
Nonstructural proteins. (i) 2A. FMDV 2A is an 18-aa peptide
similar to the C terminus of cardiovirus 2A, a protein which
induces a modification of the cellular translation apparatus re-
sulting in 2A release (19, 20). The FMDV 2A proteins examined
here averaged an 89% amino acid identity. Fourteen residues
were identified as 98% invariant, including the DVEXNPG
motif, which is essential for encephalomyocarditis virus 2A activ-
ity (21). The high level of 2A conservation likely reflects structural
and functional constraints associated with the small size of the
protein.
(ii) 2B. FMDV 2B localizes to sites of virus genome repli-
cation in ER-derived vesicles (106). The 2B protein in other
picornaviruses enhances membrane permeability, blocks pro-
tein secretory pathways, suppresses apoptotic responses by af-
fecting intracellular Ca2 homeostasis, and is implicated in
virus-induced cytopathic effects (17, 47, 112).
FMDV 2B, a protein of 154 aa, contains 117 invariant res-
idues (Table 4), with amino acid substitutions limited to only
one or two alternate residues per site. A previously unde-
scribed, conserved transmembrane domain was predicted be-
tween positions 120 and 140, suggesting that 2B is an integral
membrane protein and consistent with the proposed localiza-
tion of 2B to ER-derived vesicles (106).
(iii) 2C. FMDV 2C is homologous to poliovirus 2C, an
ATPase affecting the initiation of minus-strand RNA synthesis
and whose precursor, 2BC, induces vesicle formation in the
cytoplasm (53). FMDV 2C localizes to membrane-associated
virus-replicating complexes (106).
FMDV 2C is 318 aa long and contains 72% invariant resi-
dues, including those of the putative ATP/GTP binding do-
main (positions 110 to 116, 160 to 163, and 243 to 246) (15).
Amino acid substitutions unique to individual SAT serotypes
were identified between positions 33 and 92.
(iv) 3A. FMDV 3A has been implicated in virus virulence
and host range, similar to the 3A proteins of other picornavi-
ruses (33, 61). Deletions in 3A have been associated with
FMDV attenuation in cattle and with the porcinophilic phe-
notype of O Taiwan/97 (54). However, evidence suggests that
other viral genetic determinants are necessary for these phe-
notypes (54, 81).
FMDV 3A ranges from 143 to 153 aa, with insertions/dele-
tions preferentially occurring at positions 70 to 110 and 130 to
150, regions identified here as containing previously unde-
scribed variability. In fact, 3A is one of the most variable
proteins encoded by FMDV, with fewer invariant aa (37%)
than the variable capsid proteins 1B and 1C and the highly
variable Lpro and contrasting with the high degree of conser-
vation previously reported for a limited number of PanAsia 3A
sequences (54). As described above, 3A contains residues pre-
dicted to undergo positive selection, including the Q44 residue,
at which a Q44R mutation was previously associated with a
pathogenic phenotype in guinea pigs (78). Although the Q44R
mutation was present in several guinea pig-adapted isolates
examined here, this mutation was absent from other isolates
adapted to guinea pigs and present in still others that were not
adapted to guinea pigs, suggesting that alternative mutations
may underlie this particular phenotype. A previously described
transmembrane domain (positions 60 through 76) (54) which
tolerated conservative amino acid substitutions at all positions
except invariant residues L64, L68, A70, and I72 was also
variable in this study. Our data revealed limited variability in
the potential 3A T-cell epitope that was previously identified
between positions 21 and 35 (10). The variable nature of 3A
suggests that it may be highly informative for epidemiologic or
forensic purposes. Additionally, the likely role for 3A in viru-
lence and host range suggests that interactions with host fac-
tors underlie 3A’s variability and the diversifying selection pre-
dicted to act upon it.
VOL. 79, 2005 FMDV GENOMICS 6499
6500 CARRILLO ET AL. J. VIROL.
(v) 3B. FMDV is the only picornavirus to encode multiple
3B proteins (3B1, 23 aa; 3B2, 24 aa; and 3B3, 24 aa), whose
homologue in poliovirus primes genomic RNA synthesis dur-
ing virus replication (26, 85). In our study, 3B1, 3B2, and 3B3
were present in all FMDV isolates. The motif GPYXGP (ex-
cept for the substitution GPYXRP in Sat 1/20 Rv 11/37), which
contains a Y residue homologous to the poliovirus Y3 residue
involved in phosphodiester linkage of 3B to the 5 end of the
viral genome, was invariant in the N terminus of each protein
(5) (Table 7). The 3B C-terminal regions contained more
amino acid variability, including the majority of observed non-
conservative substitutions and the fewest invariant residues.
Notably, 3B3 was highly conserved in all isolates examined,
supporting previous experimental evidence indicating that only
this 3B isoform is essential for virus viability (26, 84). 3B1 and
3B2 were more variable, and in fact, contained residues pre-
dicted here to undergo diversifying selection (3B1 residues 4
and 11 and 3B2 residues 17, 18, and 19). These data, in con-
junction with experimental data indicating that the deletion of
3B1 and 3B2 may affect FMDV virulence and host range (84),
suggest that, similar to that of 3A, 3B1 and 3B2 protein vari-
ability reflects host range-specific functions.
(vi) 3C. FMDV 3Cpro is a 213-amino-acid proteinase in-
volved in the cleavage of most viral precursor proteins and of
host factors associated with translation (eIF4A and eIF4G)
and transcription (histone H3). A previous mutational analysis
of 3Cpro identified the catalytic triad residues C163, H46, and
D84 and residues critical for proper protein folding, i.e., D84
and Y136, all of which were invariant in the isolates examined
here (34). A previously undescribed invariant motif (VKG
QDMLSDAALMVLH) and a predicted transmembrane do-
main were identified at positions 76 to 91 and 27 to 44, respec-
tively. A high degree of overall 3Cpro conservation indicates a
limited tolerance for mutations, likely due to significant struc-
tural/functional constraints. Despite the 3Cpro conservation, 36
SAT-specific residues were identified, suggesting that distinct
selective pressures exist for the two virus groups.
(vii) 3D. The 469-amino-acid viral RNA-dependent RNA
polymerase 3Dpol, responsible for generating minus- and plus-
sense genomic RNA, is one of the most conserved FMDV
proteins. Our analysis indicated that although it is conserved,
3Dpol is more tolerant of substitutions than was previously
reported (56), as our results extended the proportion of vari-
able residues from 8.6% to 26%. D245, N307, and G295, which
are essential for maintaining the functional integrity of the
picornaviral polymerases (56), were invariant in FMDV 3Dpol,
along with other residues described as being highly conserved
among all RNA-dependent RNA polymerases (31), including
the NTP-binding residues G337, D338, and D339 (115). The
previously described picornaviral polymerase peptide motifs
KDELR, PSG, YGGD, and FLKR were conserved among all
FMDV isolates analyzed (18, 51). Finally, the three previously
described hypervariable, hydrophobic antigenic regions of
3Dpol (aa 1 to 12, 64 to 76, and 143 to 153) were also variable
in all virus isolates examined here (31).
3 UTR. The picornaviral 3 UTR binds several viral and host
proteins and is believed to contain structural cis-acting elements
required for negative-strand RNA synthesis (4). Removal of the
terminal poly(A) tract or mutagenesis of structural elements ab-
rogates the infectivity of FMDV infectious clones (98). FMDV 3
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UTR sequences stimulate virus-specific, IRES-dependent trans-
lation (67) and likely affect other aspects of viral replication,
including genome circularization (37).
The FMDV 3 UTRs were highly variable in length among
the isolates, ranging from 85 to 101 nt. A secondary structure
analysis of the FMDV 3 UTR confirmed the Y shape which is
also predicted for other picornaviral 3 UTRs, suggesting that
the structure plays an important role in the 3 UTR function
(Fig. 1D and data not shown). A previously unidentified motif
was located at the vertex of the Y structure between positions
37 and 61 (Fig. 1C and D). In some cases, however, structural
features which could conceivably affect the efficiency of ribo-
some/RNA dissociation and translation were observed (for
example, the exceptionally long stem of A10 Holland/42 and
the short stem of O2 Brescia/47) (data not shown).
FMDV phylogenetic and recombination analysis. To date,
phylogenetic analyses have been performed largely on FMDV
sequences from the 1D coding region. These analyses have
permitted the discrimination among serotypically related
FMDV isolates (55). Split decomposition, a clustering tech-
nique used previously on 1D sequences to suggest the occur-
rence of quasispecies evolution in Euroasiatic FMDV (22), was
used to examine the complete genome sequences of all 103
isolates described here (Fig. 4A). The results indicated that
complex phylogenetic relationships exist between members of
different serotypes, including relationships between the A24
Argentina/65 and European/South American O1 viruses; be-
tween A12 Valle strain 119 and C Waldman strain 149; be-
tween the O1 M11, O2 Brescia/47, and O3 Venezuela/71 vi-
ruses and European serotype A viruses; between 05India/62
and Asia1 viruses from Israel; among six SAT1 and three SAT3
viruses; and most notably, between SAT1/7 Isrl 4/62 and
SAT2/3 Kenya 11/60 and other SAT1 and SAT2 viruses (Fig.
4A and data not shown).
The data from analyses of individual protein-encoding regions
indicated that incongruent tree topologies exist for different
genomic regions (data not shown). An analysis of 1B, 1C, 1D, or
all of the structural protein-encoding regions together indicated
few obvious phylogenetic incongruities, placing viruses into sero-
typic, temporal, and/or geographic groups (Fig. 4B and data not
shown). In general, analyses of the entire structural protein-en-
coding region improved bootstrap/confidence values relative to
1D analysis alone (data not shown). Conversely, analyses of the 5
UTR and regions encoding individual or all nonstructural pro-
teins failed to produce the serotype-inclusive groups observed
with capsid protein sequences, often yielding unresolved, star-like
topologies among diverse serotypes (Fig. 4C and data not shown).
Consistent with the complex relationships illustrated in Fig. 4A,
analyses of nonstructural protein-encoding regions indicated
groupings of serotypically disparate viruses, which extended pre-
vious but limited data (54, 110, 113) (Fig. 4C). Similarity plots and
bootscanning analysis further indicated that several of these in-
terserotypically related viruses contained nonstructural protein-
encoding regions most similar to those of viruses with divergent
capsid protein-encoding sequences, suggesting the occurrence of
intertypic recombination during the history of these lineages (Fig.
4D to F and data not shown). Examples of potential intratypic
recombination were also noted, more obviously in nonstructural
protein-encoding regions but also in structural protein-encoding
regions, as has been suggested previously (Fig. 4F and G and data
not shown) (35, 109).
Taken together, these data suggest that FMDV capsid pro-
tein sequences may undergo intertypic recombination infre-
quently relative to that in other genomic regions, which con-
ceivably undergo complex recombination events and fail to
display serotype-specific phylogenetic relationships. These ob-
servations are consistent with and extend previous reports of
FMDV recombination, which has been inferred from incon-
gruent Lpro, 3Cpro, and 1D topologies and observed (and sug-
gested to predominate) in C-terminal genomic regions (52, 57,
101, 113). Similar observations have recently been made for
enterovirus genomes, which were suggested to undergo rela-
tively extensive recombination in nonstructural gene regions
while generally maintaining serospecific monophyly (79).
These observations, including the inability to reliably define
viral relationships based on nonstructural protein-encoding se-
quences and data suggestive of recombination, raise interesting
questions about FMDV genome evolution in nature and the
relative contribution of recombination to the generation of
FMDV genetic and population diversity.
Notably, the analysis described here identified a novel SAT
lineage represented by SAT1-7 Isrl 4/62 and SAT2-3 Kenya 11/60,
which contain nonstructural protein-encoding regions that are
divergent from each other but are also clearly distinct from those
of the other SAT and Euroasiatic lineages presented here (Fig.
4C). The distinct nature of nonstructural proteins from these
structurally/serotypically SAT-like viruses was supported by a pre-
viously available genome sequence similar to that of SAT2-3
Kenya (SAT2 Ken/3/57; 97% overall nucleotide identity) (Table
1) and by previous data indicating that the SAT2 Ken/3/57 Lpro-
and 3C-encoding regions may be distinct from those of other
SATs (102). Taken together, these results suggest that more
FMDV genome diversity may exist in nature than is currently
indicated by serology or 1D sequence analysis.
ACKNOWLEDGMENTS
We thank J. Lubroth for providing FMDV isolates and A. Lakowitz
and A. Zsak for providing excellent technical assistance.
REFERENCES
1. Acharya, R., E. Fry, D. Stuart, G. Fox, D. Rowlands, and F. Brown. 1990.
The structure of foot-and-mouth disease virus: implications for its physical
and biological properties. Vet. Microbiol. 23:21–34.
2. Acharya, R., E. Fry, D. Stuart, G. Fox, D. Rowlands, and F. Brown. 1989.
The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å
resolution. Nature (London) 337:709–716.
3. Afonso, C. L., E. R. Tulman, Z. Lu, E. Oma, G. F. Kutish, and D. L. Rock.
1999. The genome of Melanoplus sanguinipes entomopoxvirus. J. Virol.
73:533–552.
4. Agol, V. I., A. V. Paul, and E. Wimmer. 1999. Paradoxes of the replication
of picornaviral genomes. Virus Res. 62:129–147.
5. Ambros, V., and D. Baltimore. 1978. Protein is linked to the 5 end of
poliovirus RNA by a phosphodiester linkage to tyrosine. J. Biol. Chem.
253:5263–5266.
6. Ansardi, D. C., D. C. Porter, and C. D. Morrow. 1992. Myristylation of
poliovirus capsid precursor P1 is required for assembly of subviral particles.
J. Virol. 66:4556–4563.
7. Bandelt, H. J., and A. W. Dress. 1992. Split decomposition: a new and
useful approach to phylogenetic analysis of distance data. Mol. Phylogenet.
Evol. 1:242–252.
8. Basavappa, R., R. Syed, O. Flore, J. P. Icenogle, and D. J. Filman. 1994.
Role and mechanism of the maturation cleavage of VP0 in poliovirus
assembly: structure of the empty capsid assembly intermediate at 2.9 A
resolution. Protein Sci. 3:1651–1669.
9. Belsham, G. J. 1992. Dual initiation sites of protein synthesis on foot-and-
mouth disease virus RNA are selected following internal site and scanning
of ribosomes in vivo. EMBO J. 11:1105–1110.
6502 CARRILLO ET AL. J. VIROL.
 
10. Blanco, E., M. Garcia-Briones, A. Sanz-Parra, P. Gomes, E. De Oliveira,
M. L. Valero, D. Andreu, V. Ley, and F. Sobrino. 2001. Identification of
T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus.
J. Virol. 75:3164–3174.
11. Brendel, V., P. Bucher, I. Nourbakhsh, B. E. Blaisdell, and S. Karlin. 1992.
Methods and algorithms for statistical analysis of protein sequences. Proc.
Natl. Acad. Sci. USA 89:2002–2006.
12. Clarke, B. E., A. L. Brown, K. M. Currey, S. E. Newton, D. J. Rowlands, and
A. R. Carroll. 1987. Potential secondary and tertiary structure in the
genomic RNA of foot-and-mouth disease virus. Nucleic Acids Res. 15:
7067–7079.
13. Curry, S., M. Chow, and J. M. Hogle. 1996. The poliovirus 135S particle is
infectious. J. Virol. 70:7125–7131.
14. Curry, S., E. Fry, W. Blakemore, R. Abu-Ghazaleh, T. Jackson, A. M. King,
S. Lea, J. Newman, and D. Stuart. 1997. Dissecting the roles of VP0
cleavage and RNA packaging in picornavirus capsid stabilization: the struc-
ture of empty capsids of foot-and-mouth disease virus. J. Virol. 71:9743–
9752.
15. Dever, T. E., M. J. Glynias, and W. C. Merrick. 1987. GTP-binding domain:
three consensus sequence elements with distinct spacing. Proc. Natl. Acad.
Sci. USA 84:1814–1818.
16. Devereux, J., P. Haeberli, and O. Smithies. 1984. A comprehensive set of
sequence analysis programs for the VAX. Nucleic Acids Res. 12:387–395.
17. Doedens, J. R., and K. Kirkegaard. 1995. Inhibition of cellular protein
secretion by poliovirus proteins 2B and 3A. EMBO J. 14:894–907.
18. Doherty, M., D. Todd, N. McFerran, and E. M. Hoey. 1999. Sequence
analysis of a porcine enterovirus serotype 1 isolate: relationships with other
picornaviruses. J. Gen. Virol. 80:1929–1941.
19. Donnelly, M., L. Hughes, G. Luke, H. Mendoza, E. ten Dam, D. Gani, and
M. Ryan. 2001. The “cleavage” activities of foot-and-mouth disease virus
2A site-directed mutants and naturally occurring “2A-like” sequences.
J. Gen. Virol. 82:1027–1041.
20. Donnelly, M., G. Luke, A. Mehrotra, X. Li, L. Hughes, D. Gani, and M.
Ryan. 2001. Analysis of the aphthovirus 2A/2B polyprotein “cleavage”
mechanism indicates not a proteolytic reaction, but a novel translational
effect: a putative ribosomal “skip.” J. Gen. Virol. 82:1013–1025.
21. Donnelly, M. L., D. Gani, M. Flint, S. Monaghan, and M. D. Ryan. 1997.
The cleavage activities of aphthovirus and cardiovirus 2A proteins. J. Gen.
Virol. 78:13–21.
22. Dopazo, J., A. Dress, and A. V. Haeseler. 1993. Split decomposition: a
technique to analyze viral evolution. Proc. Natl. Acad. Sci. USA 90:10320–
10324.
23. Duke, G. M., J. E. Osorio, and A. C. Palmenberg. 1990. Attenuation of
Mengo virus through genetic engineering of the 5-noncoding poly(C) tract.
Nature 343:474–476.
24. Escarmis, C., M. Toja, M. Medina, and E. Domingo. 1992. Modification of
the 5 untranslated region of foot-and-mouth disease virus after prolonged
persistence in cell culture. Virus Res. 26:113–125.
25. Ewing, B., L. Hillier, M. C. Wendl, and P. Green. 1998. Base-calling of
automated sequencer traces using Phred. I. Accuracy assessment. Genome
Res. 8:175–185.
26. Falk, M., F. Sobrino, and E. Beck. 1992. VPg gene amplification correlates
with infective particle formation in foot-and-mouth disease virus. J. Virol.
66:2251–2260.
27. Felsenstein, J. 1993. PHYLIP (Phylogeny Inference Package), version 3.5c.
Distributed by the author. Department of Genetics, University of Wash-
ington, Seattle.
28. Galtier, N., M. Gouy, and C. Gautier. 1996. SeaView and Phylo_win, two
graphic tools for sequence alignment and molecular phylogeny. Comput.
Applic. Biosci. 12:543–548.
29. Garnier, J., D. J. Osguthorpe, and B. Robson. 1978. Analysis of the accu-
racy and implications of simple methods for predicting the secondary struc-
ture of globular proteins. J. Mol. Biol. 120:97–120.
30. George, M., R. Venkataramanan, C. B. Gurumurthy, and D. Hemadri.
2001. The non-structural leader protein gene of foot-and-mouth disease
virus is highly variable between serotypes. Virus Genes 22:271–278.
31. George, M., R. Venkataramanan, B. Pattnaik, A. Sanyal, C. B. Gurumur-
thy, D. Hemadri, and C. Tosh. 2001. Sequence analysis of the RNA poly-
merase gene of foot-and-mouth disease virus serotype Asia1. Virus Genes
22:21–26.
32. Gorbalenya, A. E., E. V. Koonin, and M. M. Lai. 1991. Putative papain-
related thiol proteases of positive strand RNA viruses. Identification of
rubi- and aphthovirus proteases and delineation of a novel conserved do-
main associated with proteases of rubi-, alpha-, and coronaviruses. FEBS
Lett. 288:201–205.
33. Graff, J., C. Kasang, A. Normann, M. Pfisterer-Hunt, S. M. Feinstone, and
B. Flehmig. 1994. Mutational events in consecutive passages of hepatitis A
virus strain GBM during cell culture adaptation. Virology 204:60–68.
34. Grubman, M. J., M. Zellner, G. Bablanian, P. W. Mason, and M. E.
Piccone. 1995. Identification of the active-site residues of the 3C proteinase
of foot-and-mouth disease virus. Virology 213:581–589.
35. Haydon, D. T., A. D. S. Bastos, and P. Awadalla. 2004. Low linkage dis-
equilibrium indicative of recombination in foot-and-mouth disease virus
gene sequence alignments. J. Gen. Virol. 85:1095–1100.
36. Henikoff, S., and J. G. Henikoff. 1994. Protein family classification based on
searching a database of blocks. Genomics 19:97–107.
37. Herold, J., and R. Andino. 2001. Poliovirus RNA replication requires ge-
nome circularization through a protein-protein bridge. Mol. Cell 7:581–591.
38. Hinton, T., N. Ross-Smith, S. Warner, G. Belsham, and B. Crabb. 2002.
Conservation of L and 3C proteinase activities across distantly related
aphthoviruses. J. Gen. Virol. 83:3111–3121.
39. Hinton, T. M., F. Li, and B. S. Crabb. 2000. Internal ribosomal entry
site-mediated translation initiation in equine rhinitis A virus: similarities to
and differences from that of foot-and-mouth disease virus. J. Virol. 74:
11708–11716.
40. Hofacker, I. L. 2003. Vienna RNA secondary structure server. Nucleic
Acids Res. 31:3429–3431.
41. Hofmann, K., and W. Stoffel. 1993. TMBase, a database of membrane
spanning protein segments. Biol. Chem. Hoppe-Seyler 347:166.
42. Hogle, J. M. 2002. Poliovirus cell entry: common structural themes in viral
cell entry pathways. Annu. Rev. Microbiol. 56:677–702.
43. Huang, X., and A. Madan. 1999. CAP3: a DNA sequence assembly pro-
gram. Genome Res. 9:868–877.
44. Huson, D. 1998. Splitstree: a program for analyzing and visualizing evolu-
tionary data. Bioinformatics 14:68–73.
45. Jackson, T., A. M. Q. King, D. I. Stuart, and E. Fry. 2003. Structure and
receptor binding. Virus Res. 91:33–46.
46. Jaeger, J. A., D. H. Turner, and M. Zuker. 1990. Predicting optimal and
suboptimal secondary structure for RNA. Methods Enzymol. 183:281–306.
47. Jecht, M., C. Probst, and V. Gauss-Muller. 1998. Membrane permeability
induced by hepatitis A virus proteins 2B and 2BC and proteolytic process-
ing of HAV 2BC. Virology 252:218–227.
48. Jonassen, I. 1997. Efficient discovery of conserved patterns using a pattern
graph. Comput. Appl. Biol. Sci. 13:509–522.
49. Jonassen, I., J. Collins, and D. Higgins. 1995. Finding flexible patterns in
unaligned protein sequences. Protein Sci. 4:1587–1595.
50. Jones, D. T., W. R. Taylor, and J. M. Thornton. 1994. A model recognition
approach to the prediction of all-helical membrane protein structure and
topology. Biochemistry 33:3038–3049.
51. Kaku, Y., S. Yamada, and Y. Murakami. 1999. Sequence determination and
phylogenetic analysis of RNA-dependent RNA polymerase (RdRp) of the
porcine enterovirus 1 (PEV-1) Talfan strain. Arch. Virol. 144:1845–1852.
52. King, A. M. Q., D. McCahon, K. Saunders, J. W. I. Newman, and W. R.
Slade. 1985. Multiple sites of recombination within the RNA genome of
foot-and-mouth disease virus. Virus Res. 3:373–384.
53. Klein, M., H. J. Eggers, and B. Nelsen-Salz. 1999. Echovirus 9 strain barty
non-structural protein 2C has NTPase activity. Virus Res. 65:155–160.
54. Knowles, N. J., P. R. Davies, T. Henry, L. V. O’Donnel, J. M. Pacheco, and
P. W. Mason. 2001. Emergence in Asia of foot-and-mouth disease viruses
with altered host range: characterization of alterations in the 3A protein.
J. Virol. 75:1551–1556.
55. Knowles, N. J., and A. R. Samuel. 2003. Molecular epidemiology of foot-
and-mouth disease virus. Virus Res. 91:65–80.
56. Koonin, E. V. 1991. The phylogeny of RNA-dependent RNA polymerases
of positive-strand RNA viruses. J. Gen. Virol. 72:2197–2206.
57. Krebs, O., and O. Marquardt. 1992. Identification and characterization of
foot-and-mouth disease virus O1 Burgwedel/1987 as an intertypic recom-
binant. J. Gen. Virol. 73:613–619.
58. Krogh, A., M. Brown, I. S. Mian, K. Sjolander, and D. Haussler. 1994.
Hidden Markov models in computational biology: applications to protein
modeling. J. Mol. Biol. 235:1501–1531.
59. Kronovetr, J., and T. Skern. 2002. Foot-and-mouth disease virus leader
proteinase: a papain-like enzyme requiring an acidic environment in the
active site. FEBS Lett. 528:58–62.
60. Kuhn, R., N. Luz, and E. Beck. 1990. Functional analysis of the internal
translation initiation site of foot-and-mouth disease virus. J. Virol. 64:4625–
4631.
61. Lama, J., M. A. Sanz, and L. Carrasco. 1998. Genetic analysis of poliovirus
protein 3A: characterization of a non-cytopathic mutant virus defective in
killing Vero cells. J. Gen. Virol. 79:1911–1921.
62. Logan, D., R. Abu-Ghazaleh, W. Blakemore, S. Curry, T. Jackson, A. King,
S. Lea, R. Lewis, J. Newman, N. Parry, et al. 1993. Structure of a major
immunogenic site on foot-and-mouth disease virus. Nature 362:566–568.
63. Lole, K. S., R. C. Bollinger, R. S. Paranjape, D. Gadkari, S. S. Kulkarni,
N. G. Novak, R. Ingersoll, H. W. Sheppard, and S. C. Ray. 1999. Full-length
human immunodeficiency virus type 1 genomes from subtype C-infected
seroconverters in India, with evidence of intersubtype recombination. J. Vi-
rol. 73:152–160.
64. Lopez de Quinto, S., and E. Martinez-Salas. 1997. Conserved structural
motifs located in distal loops of aphthovirus internal ribosome entry site
domain 3 are required for internal initiation of translation. J. Virol. 71:
4171–4175.
65. Lopez de Quinto, S., and E. Martinez-Salas. 2000. Interaction of the eIF4G
VOL. 79, 2005 FMDV GENOMICS 6503
 
initiation factor with the aphthovirus IRES is essential for internal trans-
lation initiation in vivo. RNA 6:1380–1392.
66. Lopez de Quinto, S., and E. Martinez-Salas. 1999. Involvement of the
aphthovirus RNA region located between the two functional AUGs in start
codon selection. Virology 255:324–336.
67. Lopez de Quinto, S., M. Saiz, D. de la Morena, F. Sobrino, and E. Mar-
tinez-Salas. 2002. IRES-driven translation is stimulated separately by the
FMDV 3-NCR and poly(A) sequences. Nucleic Acids Res. 30:4398–4405.
68. Mason, P. W., S. V. Bezborodova, and T. M. Henry. 2002. Identification and
characterization of a cis-acting replication element (cre) adjacent to the
internal ribosome entry site of foot-and-mouth disease virus. J. Virol. 76:
9686–9694.
69. Mason, P. W., M. J. Grubman, and B. Baxt. 2003. Molecular basis of
pathogenesis of FMDV. Virus Res. 91:9–32.
70. Mason, P. W., J. M. Pacheco, Q.-Z. Zhao, and N. J. Knowles. 2003. Com-
parisons of the complete genomes of Asian, African and European isolates
of a recent foot-and-mouth disease virus type O pandemic strain (PanAsia).
J. Gen. Virol. 84:1583–1593.
71. Mason, P. W., E. Rieder, and B. Baxt. 1994. RGD sequence of foot-and-
mouth disease virus is essential for infecting cells via the natural receptor
but can be bypassed by an antibody-dependent enhancement pathway.
Proc. Natl. Acad. Sci. USA 91:1932–1936.
72. McKenna, T. S., J. Lubroth, E. Rieder, B. Baxt, and P. W. Mason. 1995.
Receptor-binding site-deleted foot-and-mouth disease (FMD) virus pro-
tects cattle from FMD. J. Virol. 69:5787–5790.
73. Morgenstern, B. 1999. Dialign 2: improvement of the segment-to-segment
approach to multiple sequence alignment. Bioinformatics 15:211–218.
74. Moscufo, N., J. Simons, and M. Chow. 1991. Myristoylation is important at
multiple stages in poliovirus assembly. J. Virol. 65:2372–2380.
75. Murray, K. E., and D. J. Barton. 2003. Poliovirus CRE-dependent VPg
uridylylation is required for positive-strand RNA synthesis but not for
negative-strand RNA synthesis. J. Virol. 77:4739–4750.
76. Nakai, K., and P. Horton. 1999. PSORT: a program for detecting sorting
signals in proteins and predicting their subcellular localization. Trends
Biochem. Sci. 24:34–35.
77. Nei, M., and T. Gojobori. 1986. Simple methods for estimating the numbers
of synonymous and non-synonymous nucleotide substitutions. Mol. Biol.
Evol. 3:418–426.
78. Nunez, J. I., E. Baranowski, N. Molina, C. M. Ruiz-Jarabo, C. Sanchez, E.
Domingo, and F. Sobrino. 2001. A single amino acid substitution in non-
structural protein 3A can mediate adaptation of foot-and-mouth disease
virus to the guinea pig. J. Virol. 75:3977–3983.
79. Oberste, M. S., K. Maher, and M. A. Pallansch. 2004. Evidence for fre-
quent recombination within species Human enterovirus B based on com-
plete genomic sequences of all thirty-seven serotypes. J. Virol. 78:855–867.
80. O’Donnell, V. K., J. M. Pacheco, T. M. Henry, and P. W. Mason. 2001.
Subcellular distribution of the foot-and-mouth disease virus 3A protein in
cells infected with viruses encoding wild-type and bovine-attenuated forms
of 3A. Virology 287:151–162.
81. Oem, J. K., K. N. Lee, I. S. Cho, S. J. Kye, J. H. Park, and Y. S. Joo. 2004.
Comparison and analysis of the complete nucleotide sequence of foot-and-
mouth disease viruses from animals in Korea and other PanAsia strains.
Virus Genes 29:63–71.
82. Ohlmann, T., and R. J. Jackson. 1999. The properties of chimeric picor-
navirus IRESes show that discrimination between internal translation ini-
tiation sites is influenced by the identity of the IRES and not just the
context of the AUG codon. RNA 5:764–778.
83. Osterburg, G., and R. Sommer. 1981. Computer support of DNA sequence
analysis. Comput. Programs Biomed. 13:101–109.
84. Pacheco, J. M., T. M. Henry, V. K. O’Donnell, J. B. Gregory, and P. W.
Mason. 2003. Role of nonstructural proteins 3A and 3B in host range and
pathogenicity of foot-and-mouth disease virus. J. Virol. 77:13017–13027.
85. Paul, A. V., J. Yin, J. Mugavero, E. Rieder, Y. Liu, and E. Wimmer. 2003.
A “slide back” mechanism for the initiation of protein-primed RNA syn-
thesis by the RNA polymerase of poliovirus. J. Biol. Chem. 278:43951–
43960.
86. Pereda, A. J., G. A. Konig, S. A. Chimeno Zoth, M. Borca, E. L. Palma, and
M. E. Piccone. 2002. Full length nucleotide sequence of foot-and-mouth
disease virus strain O1 Campos/Bra/58. Arch. Virol. 147:2225–2230.
87. Pereira, H. G. 1981. Foot and mouth disease. Academic Press Inc., London,
United Kingdom.
88. Perez Filgueira, M., A. Wigdorovitz, A. Romera, P. Zamorano, M. V. Borca,
and A. M. Sadir. 2000. Detection and characterization of functional T-cell
epitopes on the structural proteins VP2, VP3, and VP4 of foot and mouth
disease virus O1 Campos. Virology 271:234–239.
89. Piccone, M. E., E. Rieder, P. W. Mason, and M. J. Grubman. 1995. The
foot-and-mouth disease virus leader proteinase gene is not required for
viral replication. J. Virol. 69:5376–5382.
90. Piccone, M. E., M. Zellner, T. F. Kumosinski, P. W. Mason, and M. J.
Grubman. 1995. Identification of the active-site residues of the L proteinase
of foot-and-mouth disease virus. J. Virol. 69:4950–4956.
91. Polatnick, J. 1980. Isolation of foot-and-mouth-disease polyuridylic acid
polymerase and its inhibition by antibody. J. Virol. 33:774–779.
92. Polatnick, J., and S. H. Wool. 1983. Association of foot-and-mouth disease
virus induced RNA polymerase with host cell organelles. Comp. Immunol.
Microbiol. Infect. Dis. 6:265–272.
93. Porter, A. G. 1993. Picornavirus nonstructural proteins: emerging roles in
virus replication and inhibition of host cell functions. J. Virol. 67:6917–
6921.
94. Ramos, R., and E. Martinez-Salas. 1999. Long-range RNA interactions
between structural domains of the aphthovirus internal ribosome entry site
(IRES). RNA 5:1374–1383.
95. Rieder, E., T. Bunch, F. Brown, and P. W. Mason. 1993. Genetically engi-
neered foot-and-mouth disease viruses with poly(C) tracts of two nucleo-
tides are virulent in mice. J. Virol. 67:5139–5145.
96. Rivas, E., and S. R. Eddy. 1999. A dynamic programming algorithm for RNA
structure prediction including pseudoknots. J. Mol. Biol. 285:2053–2068.
97. Rueckert, R. R. 1996. Picornaviridae: the viruses and their replication.
Lippincott-Raven, Philadelphia, Pa.
98. Saiz, M., S. Gomez, E. Martinez-Salas, and F. Sobrino. 2001. Deletion or
substitution of the aphthovirus 3 NCR abrogates infectivity and virus
replication. J. Gen. Virol. 82:93–101.
99. Saleh, L., R. C. Rust, R. Fullkrug, E. Beck, G. Bassili, K. Ochs, and M.
Niepmann. 2001. Functional interaction of translation initiation factor
eIF4G with the foot-and-mouth disease virus internal ribosome entry site.
J. Gen. Virol. 82:757–763.
100. Salminen, M. O., J. K. Carr, D. S. Burke, and F. E. McCutchan. 1995.
Identification of breakpoints in intergenotypic recombinants of HIV type 1
by bootscanning. AIDS Res. Hum. Retrovir. 11:1423–1425.
101. Saunders, K., A. M. King, D. McCahon, J. W. I. Newman, W. R. Slade, and
S. Forss. 1985. Recombination and oligonucleotide analysis of guanidine-
resistant foot-and-mouth disease virus mutants. J. Virol. 56:921–929.
102. Sawyer, S. A. 1989. Statistical tests for detecting gene conversion. Mol. Biol.
Evol. 6:526–538.
103. Schaefer, J., and M. Schoniger. 1997. DISTREE: a tool for estimating
genetic distances between aligned DNA sequences. Comput. Appl. Biosci.
13:445–451.
104. Strimmer, K., and A. von Haeseler. 1996. Quartet puzzling: a quartet
maximum-likelihood method for reconstructing tree topologies. Mol. Biol.
Evol. 13:964–969.
105. Tamura, K., and M. Nei. 1993. Estimation of the number of nucleotide
substitutions in the control region of mitochondrial DNA in humans and
chimpanzees. Mol. Biol. Evol. 10:512–526.
106. Tesar, M., and O. Marquardt. 1989. Serological probes for some foot-and-
mouth disease virus nonstructural proteins. Virus Genes 3:29–44.
107. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W:
improving the sensitivity of progressive multiple sequence alignment
through sequence weighting, position-specific gap penalties and weight
matrix choice. Nucleic Acids Res. 22:4673–4680.
108. Toja, M., C. Escarmis, and E. Domingo. 1999. Genomic nucleotide se-
quence of a foot-and-mouth disease virus clone and its persistent deriva-
tives. Implications for the evolution of viral quasispecies during a persistent
infection. Virus Res. 64:161–171.
109. Tosh, C., D. Hemadri, and A. Sanyal. 2002. Evidence of recombination in
the capsid-coding region of type A foot-and-mouth disease virus. J. Gen.
Virol. 83:2455–2460.
110. Tosh, C., M. Mittal, A. Sanyal, D. Hemadri, and S. K. Bandyopadhyay.
2004. Molecular phylogeny of leader proteinase gene of type A of foot-
and-mouth disease virus from India. Arch. Virol. 149:523–536.
111. Vakharia, V. N., M. A. Devaney, D. M. Moore, J. J. Dunn, and M. J.
Grubman. 1987. Proteolytic processing of foot-and-mouth disease virus
polyproteins expressed in a cell-free system from clone-derived transcripts.
J. Virol. 61:3199–3207.
112. van Kuppeveld, F. J., J. G. Hoenderop, R. L. Smeets, P. H. Willems, H. B.
Dijkman, J. M. Galama, and W. J. Melchers. 1997. Coxsackievirus protein
2B modifies endoplasmic reticulum membrane and plasma membrane per-
meability and facilitates virus release. EMBO J. 16:3519–3532.
113. van Rensburg, H., D. Haydon, F. Joubert, A. Bastos, L. Heath, and L. Nel.
2002. Genetic heterogeneity in the foot-and-mouth disease virus leader and
3C proteinases. Gene 289:19–29.
114. von Heijne, G. 1992. Membrane protein structure prediction: hydrophobic-
ity analysis and the “positive inside” rule. J. Mol. Biol. 225:487–494.
115. Xiang, W., A. Cuconati, D. Hope, K. Kirkegaard, and E. Wimmer. 1998.
Complete protein linkage map of poliovirus P3 proteins: interaction of
polymerase 3Dpol with VPg and with genetic variants of 3AB. J. Virol.
72:6732–6741.
116. Yang, Z., R. Nielsen, N. Goldman, and A.-M. K. Pedersen. 2000. Codon-
substitution models for heterogeneous selection pressure at amino acid
sites. Genetics 155:431–449.
117. Zucker, M. 1989. Finding all suboptimal foldings of an RNA molecule.
Science 244:48–52.
6504 CARRILLO ET AL. J. VIROL.
 
Supplement Table 1. FMDV Amplification Primers 
 
Name Position Sense                          5’-3’ Sequence 
    
F1 1  Forward TTGAAARGGGRCRMTAGGGT 
 380  Reverse CCCKAKCCCGCCTTTCACCCCCCCCCC 
F3 380  Forward CCCCCCMTAARGYYYTACCGWCRYWCCCGAC 
 1465  Reverse GCCGGTGTGGAGCAAGTYTTRATSWKCCA 
F4 649  Forward CGTCGCTYKWKGMNNACTTGTACAAACACGA 
 1660  Reverse GGGTAAAANTCCTCRTCRTCRATNGCGTACCANCC 
F5 848  Forward GGGAACTCCTCCTTGGTRACADGGACCCRCSGGGCC 
 2081  Reverse TGCCCGTTNCGGGTNGTSABRATVCGRTC 
F6 1274  Forward TTTTTACWSCAGRCCCAAYARMCACGRBAACTG 
 2476  Reverse GTCATGTTGGTTCGGGGGYTNAWRWAYTGRTG 
F7 1605  Forward TTTGCGTGTGTCACMTCCRANGGNTGGTAYGC 
 2840  Reverse GCAGAGGAAGGTNGGRCANGCYTCNGCNACRTC 
F8 1930  Forward ACACAACCAACACNCARAACAAYGAYTGGTTYTC 
 3152  Reverse GTGAATTTGGARTTCARNCCNGTRTCCCAYTC 
F9 2420  Forward GAAGTACCAGCTCACCCTNTWYCCNCAYCARTTYHT 
 3733  Reverse TTGCCAACACGCBRTGNGGYGCNGTGTANGG 
F10 2804  Forward AACCTGCTGGATGTGMGCNGARGCVTGYCC 
 4091  Reverse GAAGAAGAAGGGYCCRGGRTTGGAYTCNACRTC 
F11 3105  Forward GCCCACTGCATNCAYKCNGARTGGGAYAC 
 4396  Reverse TTCTTCACGACRAANGTRCTGTCCAGRATMTC 
F12 3690  Forward ACCCGGCTTGCNCTSCCNTWCACNGCNCCNCA 
 4990  Reverse AAGTGGTCAGGGTCDGGYGGRCARTACCA 
F13 4060  Forward ACGTTGAGTCCAAYCCYGGRCCYYTCTTCTT 
 5249  Reverse GGCGCTCACGTCRATRTCRAAGTGRAACC 
F14 4330  Forward TCCTTGTGGCBATYATGCTRGCNGACACCGG 
 5554  Reverse CTCGTGCTGNCCYTTCTCRATGAGRAAGTA 
F15 4956  Forward TGGTACTGCCCRCCTGACCCYGAYCACTTYGA 
 6250  Reverse GTCTTCCCGTCGAGGATRAGYTCRACRGGCTT 
F16 5124  Forward AAACCTTTCAAYAGYAARGTNATYAT 
 6433  Reverse ATGAGCGCGGCRTCYGARAGCATGTCCTG 
F17 5510  Forward CCCAAAARTCTGTGYTBTACTTYCTCAT 
 6766  Reverse AGCATGGACCKdGANACRCANGARCAGTA 
F18 6221  Forward GCCTGTTGAGCTYATNCTYGAYGGNAAGAC 
 7364  Reverse AGGCAGGACGTCGACRATGCGRGTYTTRCCGGC 
F19 6393  Forward AAAGTAAAAGGACAGGACATGCTYTC 
 7585  Reverse TCCTCAAACATRATGTTCATNGCRTCRCTRCA 
F20 6642  Forward ACCAAGGCTGGCTACTGYGGRGSWGCYGTYCT 
 7863  Reverse CCTCAAAGTCCARATCRTARTCACTHGC 
F21 7207  Forward ACTTCGAGAACGGCACNGTYGGRCCCGA 
 8318  Reverse AAGCAGTGGTATCAACGCAGAGTACTVN 
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Primer  
Name Sequence Forward sense 
Primer 
Name Sequence Reverse sense 
A-SEROTYPE 
AF1 TTGAAAGGGGGCGCTAG AR-1 CGGAAGGTGGTAAGAGTA 
AF2 CTCACCCCTAGCATGCCA AR-2 GGGTGAGCCAAAGCACACCAG 
AF3 CACTCCACACTTACGT AR-3 GTGACAGCCGAAGCACACCAG 
AF4 TGGATTGTGCGGACGAAC AR-4 GGGTGAAAGGCGGGTTTCGGG 
AF5 CGCTGTCTTGGGCACTCC AR-5 GCAGACGTCCCATTTCTC 
AF6 CCGTTCGACGCTCCACGG AR-6 CTCTAGACCTGGAAAGACCAGGCGG 
AF7 CGCTTCGATGCTCCACGG AR-7 TTCCCACAGCCATCATGCTCCGC 
AF8 CCCCCTAAGTTTTAC AR-8 ACCTGAAGGGCATCCTTAGCC 
AF9 CGCGCCGTCGCTTGAGGA AR-9 TCAGGCATAGAAGCTTTTTAA 
AF10 TTTCCAGGTCTAGAGGGG AR-10 AAGCCAACAGTTGTCGTGGTT 
AF11 ACAAGGACCCACGGGGCC AR-11 ACGAGGTGGTCCGCCCTCGTG 
AF12 CCTTCAGGTACCCCGAGG AR-12 TTGGAGCAAGTGTTTGATGTTC 
AF13 CTGAATAGGTGACCGGAGG AR-13 TCGTCGATCGCGTACCACCCGT 
AF14 CAACAACCACGACAACTG AR-14 TGGTACTGCTGCATGTAGTAGTTGTT 
AF15 CACGAGGGTGGACCACCCG AR-15 GTCGTTGTTCTGAGTGTTGGTTGTGTG 
AF16 CACGAGGGCGGACCACCTCG AR-16 GGTCTCCTCGGTCTTCTTGTCGGCGAG 
AF17 CTTCCACGCTGGCATCTTT AR-17 TTCTGCCTGCACCACCCGCGT 
AF18 TTTCCATGCAGGCATTTTC AR-18 CATGTATGCGAATGAGTCCACCA 
AF19 TAACAACTACTACATGCA AR-19 GGTTCTGGGGCTGATGAACTGGTG 
AF20 CACCCACACAACCAACAC AR-20 GTTTTTGGGTCTGTTGTCACCA 
AF21 CCCGCAACGGGCACACCA AR-21 GTGAAGCGTCTAGGGTAGTT 
AF22 GACGCGGGTGGTGCAGGC AR-22 GGAGACATCAAACTTGGCCA 
AF23 TCTCCTGGTGGCCATGGT AR-23 GTACGCCACCATGTAGCGGGC 
AF24 CCTTGGTGTGAACAGGTA AR-24 GAGAAAGTAAATTTGGAGTTC 
AF25 CCCGACCCACGTTCACGT AR-25 ATATGCAGACCCATCCCTGTAC 
AF26 AACAGACCCAAAAACAGC AR-26 GGGAGGCGCAACTCAAAGTC 
AF27 AACAGACCCGAAAACAGC AR-27 TATCTTCACAAATCTGTCCAT 
AF28 CGACGGGAAACCGTACGT AR-28 CAGGTCAGAGAAGTAGTACGT 
AF29 CTACGCACAGTACTCTGG AR-29 GTCTCGTGAATGGTGCCTTG 
AF30 CCATGCTGAGTGGGACAC AR-30 CAAAGTTGAAAGAAG 
AF31 CGTACAGGGATGGGTCTG AR-31 CATAGTTGAAAGATGCGGG 
AF32 CCTCCCGATTGACCCCCG AR-32 CATAGTTGAAGGAGGCGGG 
AF33 CATCATGGACAGATTTGT AR-33 CGTAGTTAAAAGAGGCGGG 
AF34 ATGTCATTGACCTCATGC AR-34 CGGCACGCTTCATGCGCACGAG 
AF35 GCCACACCGCGTGTTGGC AR-35 GTTTTGAAGGTGCAATGATCT 
AF36 AGCTTCTCGTGCGCATGAA AR-36 TTTGCAGGTGCAATGATCCT 
AF37 ACAGAAGATCATTGCACC AR-37 CTTGGAAAAATTTGACCTAAC 
AF38 AGATGCAGGAGGACATGTC AR-38 GGCCTCATCGAGACCGGT 
AF39 TGAGGAATTGGCCACTGG AR-39 CAGCATAATAGCCACAAGGAC 
AF40 GTCATGCATGGCCGCTGT AR-40 CACGTGGAAGAGACTGGAGAG 
AF41 CTTTCACGTGCCGGCCCCCG AR-41 CGGAAGAAACTCGAGGCGAC 
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AF42 GCTCAAAGCACGTGACAT AR-42 CAAACTTTTCTTCTGAGGC 
AF43 TTGCTATCCGCGACTGGAT AR-43 CCCCGGAGGCAAACGACCAC 
AF44 CCAACCTGTGCAAAGTGGTC AR-44 GTCGAAGTGGTCAGGGTCAGG 
AF45 CCTTGCAAACGTGCTCGC AR-45 TGACTTTGCTGTTGAAAGGTTT 
AF46 TGATTTGGGCCAGAACCC AR-46 ACGTCGATGTCAAAGTGGAACCT 
AF47 GGTTCATCCCGCCCATGGC AR-47 CTTCATTTCAACGGCCATGCCG 
AF48 TTAACAACAAATTGGACAT AR-48 GCTCGACCCGTTCAATCAC 
AF49 AGTACGATTGTGCCCTTCT AR-49 GAACTCAATTGCTGCTTCGTG 
AF50 GAGAAAGTGTCGAGCCACC AR-50 ATGAGGGGACGGAGCTCCTCC 
AF51 AGGAAAACTTTGAGATTGT AR-51 CGCGGATCATGATCACTATG 
AF52 AACAGATGGTGGATGATGC AR-52 CGGCGGGCTCGGAGTTCACGTCA 
AF53 GAGGCGGAAAAGAACCCT AR-53 CAGCGTAAGGTCCTTCCTGCTGTGG 
AF54 GATGGAGAGACAGAAACC AR-54 TGGGGCTCCACTCTCAGTGAC 
AF55 TACGAGGGACCGGTGAAGA AR-55 CCGTCCAGCATGATCTTGTCATA 
AF56 GATGGTCATGGGCAACAC AR-56 TCTCACGCGATTCCCACGG 
AF57 CTACCTCGTGCCTCGTCA AR-57 CCATGCACACTACAATGTCCTT 
AF58 GGACATGCTCTCAGACGC AR-58 CAGTATCCAACTCCATTGCC 
AF59 TTTCTCTGGTGAGGCCCT AR-59 GTGCAAGCTTGGTTTTGCGCAT 
AF60 GCCTACAAAGCCGCCACC AR-60 GTCAACGCCTTTTATTGCCTC 
AF61 TACTGCTCATGCGTTTCC AR-61 CCGTCAACGCCTTTTATTGCCTC 
AF62 ACCACACCACGAGGGGTT AR-62 TCGTCTTTCAGGAAGGTCTGAC 
AF63 GTCCAACAAGGACCCGCG AR-63 CAAAATCTGCCAATCATCATC 
AF64 GACAAAGCGCTGTTCCGC AR-64 CCGAATAGTCCACATCCCACACG 
AF65 AAATGCCCCACTGAGCAT AR-65 GATCCACTCAGCATTTGGGTGGAA 
AF66 GAGCTCATGGAGAAAAGA AR-66 GTGTCCAGCTCAACTCCCTC 
AF67 TGTTTTGCCTGTTGAACA AR-67 GTGTCTTTTGAGGAAAGTGACAT 
AF68 CGGACCGCAAATTGGCTC AR-68 TGGACTGCGAGTCCTGCCACGGAG 
AF69 GAACATCATGTTTGAGGA AR-69 TTTTTTTTTTTTGAAATAG 
AF70 CATCTACGTGCTCTACGC AR-70 TTTTTTTTTGAAAGGGAAGCGGG 
AF71 CACCATGATCTCCTACGG AR-71 AAGCGGGAAAAGCTCTTTCG 
AF72 AAAGGTTTTGTTCTTGGTC   
AF73 CCTTTGCACGCCGTGGGACC   
AF74 GACGAGTACCGGCGTCTC   
O-SEROTYPE 
OF1 TTGAAAGGGGGCGCTAGGG OR1 GCGTGAAGCGGCGTTCGTCCGCACA 
OF2 GCTAGGGTCTCACTCCTA. OR2 ACGGCCCCCAACRGGAGTGCCC 
OF3 CCCGCGTCGCACTCCACA  OR3 GGTGTGGAGCAAGTGYTTRATGTTCC 
OF4 AGCTGGATTGTGCGGACGAAC OR4 GGGGGGGGGGGTGAAAGGCGGGC 
OF5 CACTCTCCGCCTACTTGGTC OR5 ATTTCTCATGAAAACGGGCAAAAC 
OF6 GCCCGCCTTTCACCCCCC OR6 CATAGATCGTGTTTGTACAAGT 
OF7 CCCCCCTAAGTTTTACCG OR7 GTGGAGTCAAGCACAGTACAAA 
OF8 GGGAGGTAACCACAAGCTT OR8 GCCGTGCTGGGGTTGCACACATG 
OF9 AGTTTTGCCCGTTTTCAT OR9 CCCAGTCCCCTTCTCAGATCCC 
OF10 TGCGCACGAAACGCGCCGTC OR10 CAGTGTTTTAATCTCTCTGA 
OF11 CCCGCCTGGTCTTTCCAGGTCT OR11 CCAGCAGTTGTCGTGKTTGTTGGG 
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OF12 GTGTGCAACCCCAGCACGGCA OR12 CAGGTGAGTHGTAGACCCAGTC 
OF13 ATAGGTGACCGGAGGCCGGC OR13 GAGCAAGTGYTTRATGTTCCA 
OF14 CAACTGACTGTTTYATCGCT OR14 CGTCRTCAATCGCGTACCACCC 
OF15 CTTCACAACGGTGAGAAGAA OR15 CTGGTACTTGCTGCATGTAGAT 
OF16 CTACGACTCRCCNGAGAACCTCAC OR16 AGTGAGGATGCGGTCYTCGAG 
OF17 CCCGCTCTCGTBATYTGGAACAT OR17 CGGGTCACTGGTGACCCAGTC 
OF18 GCTGTGTTCGCSTGYGTYAC OR18 CGTCCGTGGGTTGATGAACTGGTG 
OF19 GGTTTTTGTYCCGTACGATCAG OR19 CCGCAACCATRACCACRAGGGTCC 
OF20 CAGGGGCGCYGGRCAATCCAG OR20 CTCTTTGGAAGGGAACTCACCCGC 
OF21 CAATGGACACVCARCTTGG OR21 GCGGGGTGGGTTGAACACTTTCCC 
OF22 CCCAGAACAAYGAYTGGT OR22 CCGAATCCGTCTTCGTGGTCACGTA 
OF23 CTCGARGACCGCATCCTCACT OR23 CTGTACTGTGTGTAGTACTGGGCAAG 
OF24 GAACGGTTYTTCAAAACCCAC OR24 GATGCAATGTGCAGCCGCCTCAGG 
OF25 CTGACCACAAAGGTGTCTACGG OR25 CGGCAGACYCAGCTCAAAGTC 
OF26 GGGTAACCAGTTCAAYGGAGG OR26 TGYGTYTCRCCRCCGTAGTTYTC 
OF27 CGCTACGACCAGTACAAG OR27 TTGGCTTGACTTTCACGAACCTGTC 
OF28 GGTTACGGYGGYYTGGTGAC OR28 GTGGTGTCGACTTTCAAAATCTGTC 
OF29 CCTCCTTGATGTGGCTGAGGC OR29 GCTGTTGGGTTGGTRGTGTTGTCCA 
OF30 CGGTGACGTDCCRTACGTGAC OR30 CCGTACTTGCAGTTCCCGTTGTA 
OF31 CTGCACTTCATGTTCACRGG OR31 GAGTTGCCTTGATGGCRCCGTARTTGAA 
OF32 CGCCCCHCCWGGYATGGA OR32 GGGTGCCACAATCCTCTGTTTGTGTCTA 
OF33 CGCCGAGACCACAAAYGT OR33 GTTGACATGTCCTCCTGCATCTGGTTGA 
OF34 GTGCTGGYAARGACTTTGA OR34 CTTAGAAGTTTGATGAGCTTGTACCAGGGC 
OF35 GAACTACGGTGGTGAGACACA OR35 GATGGCCACAAGGACTGGGTCCTT 
OF36 AAACTACGGTGGCGAAACNCA OR36 CGAAACTGAAGACGGGGGCCGGCACGTG 
OF37 GTGTTGGACCTGATGCA OR37 CGTTGATGTCACGTGCTTTGAGCTG 
OF38 CATGGACAGATTTGTGAARGT OR38 CATGCCTTRATCCAGTCGCGGATGGC 
OF39 GCGAACGGCCACCTACTACTT OR39 ACGTTCCCGCTCTTCAAACACGCTTG 
OF40 CCGTACCGCCACTTACTATTT OR40 CCACGGGTTCGGGCCTCGACYTGCT 
OF41 CCCAACAGCHTACCACAARG OR41 GGTCAGGGTCAGGTGGGCAGTACCA 
OF42 CTTAGCGACCGTCTACAACGG OR42 CCTTGCCGTCRGGGTTCTGGCCCAA 
OF43 GTTGGCNACYGTBTACAACGG OR43 GGTAGCGATGATGACYTTGCTGTT 
OF44 CCTACCTCCTTCAACTWCGGTGC OR44 GCGCTCACGTCRATGTCAAAGTGRAACC 
OF45 CCTACCTCCTTCAAYTWCGGYGC OR45 TTCAACGGCCATGCCGTTGAGAAG 
OF46 TACTCTACAGAATGAAGAGRG OR46 CCACCCGCTCAATCACCTCCTGAAC 
OF47 TACTCTACCGNATGAARAGRG OR47 GCTTCGTGCTGGCCCTTCTCAATGAG 
OF48 TGTGGCACCCGCAAAACAGCTT OR48 TCTCAAAGTTCTCCTTCAGGCGCTT 
OF49 TGTGGCACCKGTGAAACAGCT OR49 CGTCTCCAGAGGGTTCTTTTCCG 
OF50 GATGCAGGAGGACATGTCAAC OR50 GGCCCAGCGTAGGGTCCTTCAGCT 
OF51 CCAAGGACCCAGTCCTTGTGGC OR51 GCTTTCACTTTCAAAGCGACAGG 
OF52 GTCGCCTCGAGTTTCTTCC OR52 GCCCATGACCATCTTTTGCAAGTC 
OF53 GAACGGCGAGTGGCTGGTCAA OR53 CTTTAATCTCAAACTCAAACACTCTG 
OF54 TCCTTGCCATCCGCGACTGG OR54 GTAGGCAAAGAGGCCAGGCATGGTGTC 
OF55 CGCGCGTCAAGCGTGTTTGAAGA OR55 GTCMACWATCAACCCCTCGTGGTGTGGTTC 
OF56 GGTCGTTTGCCTCCGTGGCAA OR56 GGTGGGCGCGAGCTTGGTTTTGCGC 
OF57 CTGACCACTTCGACGGTTACA OR57 CAGCGCGGAGACAGCGCTTTGTCCTC 
OF58 CGGGGTTYATCCCGCCCATGGC OR58 CGGCGTTTCCCCTGGAGAGCCCAGGG 
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OF59 CCAACCTGTACTCGGGCTTCACCCC OR59 CGGGCGAATCTCGTCCTTCAGGAAGG 
OF60 AATTAACAACAAATTGGACAT OR60 GAGCACAGAATCTGCCAATCATCAT 
OF61 TACGACTGTGCCCTTCTCAACGG OR61 GTGTGCCAAATCTTTGCCAATCAAC 
OF62 CGAGAAAGTGTCGAGCCACC OR62 GAACACCTCCTCRAACATGATGTTCAT 
OF63 GATGGTCCAYGACTCCATCAA OR63 GTTCAAAATTGTGTTGATGATGC 
OF64 CGCGCYTTCAAGCGCCTGAA OR64 CACTTGCCACCACGATGTCGTCTCC 
OF65 CCGCGAGACTCGCAAGAGAC OR65 GAACAAAACCTTTGTCGCTTTTGTC 
OF66 GCTCCGCCAAGCGCGCAAGAGG OR66 GGAAGTGTCTTTTGAGGAAAGTGAC 
OF67 GAGGCGGAAAAGAACCCTCT OR67 CTTCTCCTGTATGGTCCCACGGCGTGC 
OF68 CCGCGAGCTGAAGGACCCTAC OR68 GATTATGCGTCACCGCACACGGCGTTC 
OF69 GCCCCGGTCGTGAAGGAAGGACC OR69 CCTACGGYGTCGCKCGCCTCAG 
OF70 GATTGTCACTGAGAGTGGTGC OR70 TTTTTTTTTTTTTTGAAATAGGAAGCGGGA 
OF71 GAGAAGTAYGACAAGATCATG   
OF72 CTACAGAGTGTTTGAGTTTGAGAT   
OF73 GAACCGCGTGAGDGACATCACGAA   
OF74 GGACGGAGCCGASACNTTCATCGT   
OF75 CCATGCTNCTTAAAATGAAGGCACA   
OF76 GCCGCCTTGTCCAACAAGGACCCGCG   
OF77 CGATGTAATTTTCTCCAAACACAA   
OF78 GTCGACGGACTTGACGCCATGG   
OF79 GCTCATCGACTTCGAGAACGGCAC   
OF80 CACCAGGATGATGATTGGCAGATT   
OF81 GCAGYGAYGCVATGAACATCATGTT   
OF82 GCATCATCAACACAATTTTGAAC   
OF83 GAGCTGGACACTTACACCATGATCTC   
OF84 CAAAAGCGACAAAGGTTTTGTTCTTGG   
OF85 GGAACTGGGTTTTACAAACCTGTGATGGC   
OF86 CGTGGGACCATACAGGAGAAGTTGATCTC   
OF87 CCAAGCTACAGATCACTTTACCTGCG   
C-SEROTYPE 
CF1 GAAAGGGGGCGCTAGGGT CR1 CGTCCGCACAATCCAGCT 
CF2 GCGCTAGGGTCTCACCCC CR2 AAGTAGGCGGAAGGTGGT 
CF3 GGCACCGCGTGGCCATTT CR3 GGCCCCATCACCGTAGT 
CF4 ACCTTCCGCCTACTTGGT CR4 AAACCAGGCGATCAGC 
CF5 CTAAGTTTTACCGTCTGT CR5 GTGAAAGGCGGGTTTCGGG 
CF6 TACCGTCTGTCCCGACGT CR6 GGGGGGGTGAAAGGCG 
CF7 CGCCTTTCCCGGCGTTAA CR7 GTTTCGTGCGCAGACGTCCC 
CF8 CACGAAACGCGCCGTCGC CR8 ACCTGGAAAGACCAGGCGGAG 
CF9 CCGCCTGGTCTTTCCAGG CR9 ACAGTGCTGTTACTAAC 
CF10 GCTTCGTAGCGGAGCATG CR10 GGCCCCGTGGGTCCTTG 
CF11 TGTGCAACCCCAGCAC CR11 GGGCATCCTTAGCCTG 
CF12 GTACCCCGAGGTAACACG CR12 CCTATTCAGGCATAGAAGC 
CF13 CTGAATAGGTGACCGGAGG CR13 GTGAATTCCATTTTTCCTG 
CF14 GACTGTTTTATCGCTGTGG CR14 GAAGGATGGTGTTCAACC 
CF15 CAGTTGTTCAGGTACGTCG CR15 GCGTGAGGTTCTCGGGCG 
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CF16 GCAACTGGAGGAACTCAC CR16 CTTGATGTTCCAAATCAC 
CF17 CTTCGCGACCCAGCGAGGT CR17 TGGAGGTGACACACGCAAA 
CF18 CTTTGCGTGTGTCACCTCC CR18 TGGAACAAATACCAGGAC 
CF19 CGATCAAGAGCCACTCAA CR19 GTTGCCAGATTGGTTCTG 
CF20 ACCAATCTGGCAACACTG CR20 GTGTCCGTGGAGCCTTC 
CF21 AAACTCCATGGACACACA CR21 AAGGGCGCCGAAAAGACC 
CF22 CCTTCAGCGGTCTTTTCGG CR22 CGCTCGACTGGGTTGTCG 
CF23 CACATTCGGGTATGCAAC CR23 GAACAACCTTGTGCATGT 
CF24 CACAAGGTTGTTCTGCCC CR24 GAACAACCTTGTGCATGT 
CF25 AAACCAGTTCAACGGCGG CR25 CGGGGACGAGCGCCACCA 
CF26 CATGACGGCACACATCAC CR26 GGCACAGTGATGTGTGC 
CF27 GTATGCCAACATAGCCCC CR27 GTTGGGGCTATGTTGGC 
CF28 ATGGTGACAACTGACCCG CR28 TCGGGTCAGTTGTCACCA 
CF29 GGGCGGTTCACAAACTAC CR29 GTTTGTGAACCGCCCCGGCA 
CF30 ACCTTACGTCTCAACACG CR30 GTTCGTGTTGAGACGTA 
CF31 GTACACTGGGACAATCAA CR31 GTGTAGGTTGATTGTCCC 
CF32 CTGCCCACTGCATACACG CR32 GTATGCAGTGGGCAGCCTC 
CF33 GTGGGTCTGTGTGTACCA CR33 CGCGTAGTCAGCGGCCGA 
CF34 GCTACCTGTGGACGCTAG CR34 CCACAGGTAGCCGGAGCTC 
CF35 TCGCCACCACACCGACGT CR35 CTCTCCTCCGTAGTTCTC 
CF36 GGGTGCCCAACGGTGCA CR36 GTAGTACGTGGCTGCGCG 
CF37 GCCACACCGTGTGTTGG CR37 GTGCACCGTTGGGCACCC 
CF38 GTTGCTCGTGCGCATGAA CR38 CAACACACGGTGTGGCGC 
CF39 GTGATAGACACAAGCAAC CR39 CTGCACCAAAGTTGAACG 
CF40 GATGCAGGAGGACATGT CR40 CGAGCGGTTGCTTGTGTCT 
CF41 CAAACCCTGGTACAAGCT CR41 GGCCCAGGGTTGGACTC 
CF42 GTGGCCATCATGCTGGC CR42 CCTGATGGCTTTCACTCCA 
CF43 GATCTCCGACTCGCTCTC CR43 GGCCACAAGGACTGGGTC 
CF44 TTCTTCCGGTCCACACCC CR44 CGTGAAAGAGACTGGAGAG 
CF45 TGCCATCCGCGACTGGAT CR45 CTGTTTCTCTGCTCTCTC 
CF46 CCCAAGCAAGTACAAGGA CR46 CCAGTCGCGGATGGCAAG 
CF47 ACCCAGCAAGTCGAGACC CR47 GTCGTTGAGGTCCCGCTG 
CF48 CCTTGCGAACGTGCTTGC CR48 GGGTCTCGACTTGCTGGG 
CF49 CGATTTGGGCCAGAACCC CR49 AGCACGTTCGCAAGGAAAC 
CF50 TCCCGCCCATGGCATCACT CR50 GAAGTGGTCAGGGTCAGG 
CF51 TGACATCGACGTGAGCG CR51 GGGTTTGCCTTTGTCCTC 
CF52 GCACTTGAAGACACCCAC CR52 CGGGGTGAAGCCCGAGTAC 
CF53 AACCACCCCTCCAGAACG CR53 GTGGGTGTCTTCAAGTGC 
CF54 CAAAAATCTGTGTTGTAC CR54 CTGGAGGGGTGGTTGAGG 
CF55 CTCCGGCCCCTCATCCAAC CR55 CACAGATTTTTGGGAAGG 
CF56 TGTCATCATGATCCGCGA CR56 TTGGATGAGGGGCCGGAG 
CF57 GACGAGGCGGAAAAGAAC CR57 GAGTCTCGCGGATCATG 
CF58 GGCGCGCGATGACGTGAAC CR58 GGGTTCTTTTCCGCCTCG 
CF59 CTGAAAGTGAGAGCCAAGC CR59 GTTCACGTCATCGCGCGCC 
CF60 GCCTGTCGCTTTGAAAGTG CR60 GACGCTCGAGTGGCCCGGC 
CF61 CTCATCCTCGACGGGAAG CR61 AGGCTTCTTCACCGGTCC 
CF62 ATGACAAGATCATGTTGGA CR62 GCCCATGACCATCTTTTGC 
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CF63 AGGACAGGACATGCTCTC CR63 AAAGATGACGAGGCACGAGG 
CF64 AGCAAGAATGAAGAAAGG CR64 GCGTCTGAGAGCATGTCC 
CF65 ACATTGTAGTGTGCATGG CR65 TGCTACATCACGAAAGTG 
CF66 TAAGGACGGAGCTGACAC CR66 CTACAATGTCTTTGTAGG 
CF67 GAGATGTGGAAGAGCGCG CR67 GAAGGTGTCAGCTCCGTCC 
CF68 CAATCCTGAGTTCGGGCC CR68 GGTATCAACGATCAACCCC 
CF69 AGCGCTGTTCCGCCGCTG CR69 AGGATTGAACACACCGTG 
CF70 CGTTGACGGACTCGACGC CR70 GAACAGCGCTTTGTCCTCC 
CF71 GCCTTGAAGCTCATGGAG CR71 CGTAAATGCTCAGTGGGG 
CF72 GACTCGCATTGTCGACGT CR72 TCCGACCGTGCCGTTCTC 
CF73 GCGGTCGGTTGCAACCCT CR73 CCTTCAGGAAGGTCTGGC 
CF74 ACTATTCGGCCTTTGAT CR74 ATCTGCCAATCATCATCC 
CF75 CCTGAAGACTCTCGTGAA CR75 TAGTCCACGTCCCACACG 
CF76 TTTGAATAACATCTACGT CR76 CTCCGTGCGGAACACCTC 
CF77 CATGATCTCCTATGGAGA CR77 GCCTTCAACAGTGATGCG 
CF78 TTTGTTCTTGGTCACTCC CR78 CGCCGCACACGGCGTTCA 
CF79 CCTCTCCTTTGCACGCCG CR79 GAGACGCCGGTACTCGTC 
CF80 CTTTGAGCCCTTCCAGGGC CR80 CTTCGAGGCCATCACAGG 
CF81 GGTGAACGCCGTGTGCGG CR81 CGCTTTTGTCAGCTGGAG 
CF82 GAAAGGGGGCGCTAGGGT CR82 CCATAGGAGATCATGGTG 
CF83 GCGCTAGGGTCTCACCCC CR83 CCCTTTCGGGCTTTTCACTCC 
CF84 GGCACCGCGTGGCCATTT CR84 GCTTTTGGATTAAGGAAGTGGG 
CF85 ACCTTCCGCCTACTTGGT CR85 TTTTTGCTTTTGGATTAAGG 
CF86 CTAAGTTTTACCGTCTGT   
CF87 TACCGTCTGTCCCGACGT   
CF88 CGCCTTTCCCGGCGTTAA   
CF89 CACGAAACGCGCCGTCGC   
CF90 CCGCCTGGTCTTTCCAGG   
CF91 GCTTCGTAGCGGAGCATG   
CF92 TGTGCAACCCCAGCAC   
CF93 GTACCCCGAGGTAACACG   
CF94 CTGAATAGGTGACCGGAGG   
CF95 GACTGTTTTATCGCTGTGG   
CF96 CAGTTGTTCAGGTACGTCG   
CF97 GCAACTGGAGGAACTCAC   
CF98 CTTCGCGACCCAGCGAGGT   
CF99 CTTTGCGTGTGTCACCTCC   
CF100 CGATCAAGAGCCACTCAA   
CF101 ACCAATCTGGCAACACTG   
CF102 AAACTCCATGGACACACA   
CF103 CCTTCAGCGGTCTTTTCGG   
CF104 CACATTCGGGTATGCAAC   
CF105 CACAAGGTTGTTCTGCCC   
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SAT-SEROTYPES 
SF-1 TTGAAAGGGGGCGCTAGGGTC SR-1 CAGCTATCCGGGCCAGGTGA 
SF-2 TTCCGTTCACCCACCTTT SR-2 GGCCCCAAAAGGGCACAGTAGC 
SF-3 AGGCAGGAACCACCCTTT SR-3 GAAACGGCGTCAACACCGTA 
SF-4 AGTACTCTTACCACTT SR-4 GGAGGGACGCTAAAACCGTA 
SF-5 CGCAGTCGTACCTCCT SR-5 GCGTTTCGTGCGCTGACGTCCC 
SF-6 CGCGGCCGACTCGCCTAC SR-6 GTAGACCAATCGTGGAGTTGG 
SF-7 CCTGCCTTTCACCCCCCC SR-7 CAGAAACCAAGTACCAGTCTC 
SF-8 CGTTAAAGGATTGTAACCA SR-8 TAAAGGAAAAGGTGCCGGC 
SF-9 AACAGTTTTGCCCGTTTTC SR-9 GGATGGTGTTCAACCAGCAGT 
SF-10 AAGCAGGTTTCCTCAACTG SR-10 CAACAGTGAGTTGAGCCAACAGT 
SF-11 TTGCTTCGTAGCGGAGCA SR-11 GTGTAGAGCAAGTGTTTGAT 
SF-12 GTGTGCAACCCCAGCACGG SR-12 GTTTGAAGACAGCCCTTGAT 
SF-13 GGCTAAGGATGCCCTTCAGGT SR-13 ATCAGATGGGTCTGGTGTCCA 
SF-14 CTATGCCTGAATAGGTGA SR-14 GTTCTCAGGGTCAGGTGTCCA 
SF-15 AATTCACACTCTACAACG SR-15 TCACCAAGTTGGGTGTCCAT 
SF-16 ACGAAAGATGGAGTTCAC SR-16 GTGGACGTAGTACCGTG 
SF-17 CTCTTTCGATACGTCGA SR-17 GTTGATGTGGTGGTACCATG 
SF-18 GCCATTCTTCGACTGGGT SR-18 TCGAACAGCTTCTGCTTGAA 
SF-19 AACAGCTGGAGGAACTCAC SR-19 AACAAGCATCCTCCGTTGAA 
SF-20 AACAGCTATCTGATTACAC SR-20 CGACACCCAGGTACGGGACCTG 
SF-21 GACGGTACTGACATGTGTC SR-21 GCCTGCCACATGCACGTTGGT 
SF-22 GATCTGTGTCATAAACGG SR-22 TAGCCTGTGCGTGGGGCGTTG 
SF-23 CATTGACGACGAGGACTT SR-23 TAGCCAGTGCGAGCCGGGTTG 
SF-24 ACGCCATTGATGACGAG SR-24 CAGTCGTTCCTAGACGGGTTG 
SF-25 CAACAACTACTACATGCA SR-25 TGTGTCCAAATGCCAAATCAA 
SF-26 ACAGAACAACGACTGGTT SR-26 TGTGGGTAAAAGCCACGTCAA 
SF-27 ACAGAACAACGATTGGTT SR-27 GAGTTCAGTCCAGTGTCCCA 
SF-28 GACAAGAAGACAGAGGA SR-28 ATCTGATACACTCCGACCCA 
SF-29 GACAAGAAAACAGAAGA SR-29 CCCCTTCGCCTGCGCTGGTTGT 
SF30 TGGGGGTGACCTACGG SR-30 TCACCGGCGGATGTTGTTTGTCTC 
SF31 TGTGACACACGTGTTGGA SR-31 CCCTCACCCGCACTAGTTGTCTGG 
SF32 GAGAAACGGTTGGGACGT SR-32 CCCACTAGTGTGAATCTGTC 
SF33 CCCTCGGACCAACACCAC SR-33 TCAGCGAAGTAGTACGTGGC 
SF34 CACACTCTACCCACACCA SR-34 GTAAGGGATTGCAAAACGGGT 
SF35 AATCGTACCTGTTGCGTGT SR-35 GCCAGTGTTGCGAGGTC 
SF36 TGAAGTCTACGTGAACAT SR-36 TGTGCAAGGACTGCGAGGTC 
SF37 CGGTCACGTGTACAACCC SR-37 GCCGCCAGCGCAGCGCGATC 
SF38 AGCCGARGCGTGYCCCAC SR-38 TGCGCCAGCACGGCGAGATC 
SF39 ATCTGCACTTCATGTACTC SR-39 TGAAAGTGGTTGGAATGTGTG 
SF40 CCACGCAGAGTGGGATAC SR-40 CCTCTGCCTGTGTGTAAATC 
SF41 CCAGGTGACTGACACACA SR-41 AACATGCCCAAAGTTGAA 
SF42 CCCAACCACTCACGGTGG SR-42 TCAGTTGAAGCGTGGTCGTA 
SF43 AACGTGGATCTGATGGACAC SR-43 TCTCCCGCCAACTTTAACAG 
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SF44 GGTAGGCGCAATCCTGCGC SR-44 TCCTTGATAGCCTTCACTCC 
SF45 CGCTGTGCCATACACTGT SR-45 CACGTGAAAGACACTGGAGAG 
SF46 TGGCAACAGTGTACAACGG SR-46 GAGCTGTTTCTCTGCTCTCTC 
SF47 TGCCACAGTTTACAATGG SR-47 TTTCTCCAAGATACCAGGCAC 
SF48 CACTTTCAACTACGGCAGGAT SR-48 CTTGGTGCCGGTGCTGTGAC 
SF49 GAAGCGGTTGACGTGTACTA SR-49 GGCTTGTGCAAGCACGTTCGC 
SF50 CTGACACACTACGACCAC SR-50 AGGGTCAGGTGGACAGTACCA 
SF51 CCAGGCCACTTCTCCCGG SR-51 AGAAGCCATGGGCGGGATGAA 
SF52 ACAATTCAGCACGCTTCAT SR-52 TACGGTTCAGTGCATCAGGGCA 
SF53 ACCCTGGGCCCTTCTTCTTCT SR-53 GGGTTTGTGTGGGTGTCCTC 
SF54 TGGTGACCGCATTTGAGG SR-54 TCGGCGGTTGAGGCTTGAACA 
SF55 TATGGCCGCTGTAGCAGCA SR-55 AAGGAAGTGAGATCTGTTTGAA 
SF56 TGCTAGCTGACACCGGTC SR-56 TCCTTCAAAGAATTCAATTGC 
SF57 GCTGGCAGGTTTGGTCAA SR-57 GCGTGTTTCGCGGATCATGAT 
SF58 AGCACGTGACATCAACGAC SR-58 GTCTTGTCGTCGGTGGTGATG 
SF59 TCTCCTCAGAAGAGAAGTT SR-59 CAGGCTCGGAGTTCACGTCAT 
SF60 CGAGAACGCCCGCCAGGC SR-60 CGGACCGGCGTAAGGCCCCTC 
SF61 CAAGTCAAGACCCGAACC SR-61 TGGCGCTCCACTCTCCGTGAC 
SF62 TGGCAGAACCGACTCTGT SR-62 CGAAAAGATGACGAGGCACGAG 
SF63 CAAGGACTTCAAGTACTT SR-63 TCCAAACTCAAACACTCTGAA 
SF64 CTTGTATTCTGGGTTCAC SR-64 CCCAACGTCAGCGTTGTTG 
SF65 TGGACATCATCAAAGCACT SR-65 TCAGGGTCAACGTGTGTGCCTTCAT 
SF66 ATGATTGTGCCCTTCTCAA SR-66 GCTTGGTTTTGCGCATGACGTG 
SF67 GTCAACCTCCACGAGAA SR-67 GCTTCTTGTCTTCCTCAGACAT 
SF68 CATCGAGAAAGGACAGCA SR-68 GCCACGGCGCTTCCCCTGG 
SF69 GGAAAACTTTGAGATCGT SR-69 TTGTACTCCCTTTTCTCCAT 
SF70 AGGCGGAAAAGAACCCTC SR-70 GGCCCGTTATTGGAGTGCAT 
SF71 AGCTGAAGGACCCTACGC SR-71 ACCTCCTCGAACATGATGTTCA 
SF72 CGAGGGGCCAGTGAAGAA SR-72 ATACCGCCTTCAACAGTGAT 
SF73 CGACTTGCAAAAGATGGT SR-73 TTGTCGGCTGGGGTGATGGT 
SF74 TGCCTCGTCATCTTTTCGC SR-74 CGGCGTGCAAAGGAGAGGAT 
SF75 TAAAAGGACAGGACATGCT SR-75 TTATGCGTCACCGCACACGG 
SF76 GGCGTGGTCAACAAC SR-76 GGCCTTTTCACTCCTACGGCG 
SF77 TGGGAGACTCATCTTCCT SR-77 CTCGCCTCAGAGTCTTTCTGCCA 
SF78 GACTTTTATCGTCGGCAC SR-78 TTTTTTTTTTGGATTGAG 
SF79 GCTCCTGCAGATGAAGGC SR-79 TTTTTCGCAAAAATCAGG 
SF80 ACCAAGCTTGCACCCACCGT   
SF81 GGTGATCTTCTCCAAACA   
SF82 GCAAATGCCCCACTGAGC   
SF83 ACGGCACTGTCGGACCCGA   
SF84 ACGGCACGGTCGGGCCCGA   
SF85 TGTCAGACCTTCCTGAAG   
SF86 CAAGAATGATGATTGGCA   
SF87 CGGTTGCAACCCTGATGT   
SF88 CGCCATGAACATCATGTT   
SF89 CAACACGGAGCACGCCTA   
SF90 CATGATCTCCTACGGAGA   
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SF91 CACCCCAGCTGACAAAAG   
SF92 GGCTTCGAAGACCCTCGA   
SF93 GTTGATCTCCGTGGCAGG   
SF94 CTTCGAACCCTTTCAGGG   
ASIA1-SEROTYPE 
HF-1 TTGAAAGGGGGCGCTA HR-1 GTGTTCGTCCGCACAATCCA 
HF-2 TTGCACTCCACACTTA HR-2 GTAAGAGTACTAACCGGTCACG 
HF-3 GGCACCGCGTGGCCAT HR-3 CGGGCGTCGGGTGACAGCCGAA 
HF-4 TAGCGCTGTCTTGGGCAC HR-4 GCGGTGCAAGCTTGTGGTTAC 
HF-5 GTGTGCTTCGGCTGTCAC HR-5 CGTTTCGTGCGCAGACGTCCC 
HF-6 CTCCCGACGTTA-AAGGGA HR-6 CTCCGCTACGAAGCAACAGT 
HF-7 CAGTTTTGCCCGTTTTCA HR-7 GCCGTGCTGGGGTTGCACACAT 
HF-8 TTCCAGGTCTAGAGGGGT HR-8 CCTTAGCCTGTCACCAGTG 
HF-9 TGCTTCGTAGCGGAGCAT HR-9 TTTTTAAACTGGGCACTTTTA 
HF-10 TGCAACCCCAGCACGGCA HR-10 GTCGTGCTTTGATCTCTCTGA 
HF-11 ACCCCGAGGTAACACGCG HR-11 GCAGTTGTCGTGGTTGTTGGG 
HF-12 CCGGAGGCCGGCGCCTTTC HR-12 CCCTCGTGCAGCTCAAGACC 
HF-13 AGAAAAAATGGAATTCAC HR-13 CAGCCAGGCACATGTCCG 
HF-14 ACCTTTCTTCGACTGGGT HR-14 CTTGAGTCGTTTCTGAACCTT 
HF-15 CCAGCGAGGTGTGTATGGT HR-15 GGGTGTTGTTTGTGTGTGTGG 
HF-16 CACCTCCAACGGGTGGTA HR-16 CAACGCTCGACTGTGTCGTCG 
HF-17 TTACCCTTGGACGCCGGA HR-17 CAAACAGGTGTTTCTTGAA 
HF-18 GCAACACTGGAAGCATCAT HR-18 CCCACCCGTTCCTCATGTA 
HF-19 AGAGACAACHCTGCTTGA HR-19 AAAAGGGTCAACTGGTACTT 
HF-20 CGACGTCGACGACACAGTC HR-20 CACAACAAGCGTCCACGG 
HF-21 TTGTCATTTGGACACTGT HR-21 CTGTGGTCACCATGTTGCC 
HF-22 CCCGGAGCTGAAAAGCCT HR-22 AGGAAGGTTGGACATGCCTC 
HF-23 ACCAGAATTGAAGGAACT HR-23 GTAGGTGTTGGACATGTGCCC 
HF-24 CTCACATCAACGTGCCGT HR-24 GTATGTAAGCCACCATGTA 
HF-25 GGTTTACATGAATGCAGC HR-25 GCCACGTCAGAAGCAGTGTA 
HF-26 CACAGACCCGAAGACGGC HR-26 GATTCGCCAGCAGTGGTGGT 
HF-27 TTGTGAAGACGGTGAACTC HR-27 GTGAGTTTCACAAACCTGTC 
HF-28 GGCGCAGTACTACACACA HR-28 GGGCGCGCCGTTGGGCACCC 
HF-29 TGAGTGGGACACTGGTCT HR-29 GGTAGGCAGTTGGGTTGGT 
HF30 CCTCTCTGCTGCTGACTA HR-30 GCAAAGGCCTAGGGCAGTATG 
HF31 GCACGCCAGCAGACCACC HR-31 AAAGTGGTCTGGGGCAGTA 
HF32 TGAGAACTACGGAGGAGA HR-32 CTCAGGTGCAATGATCTCCTG 
HF33 CACACACTGGTTGGGACG HR-33 TGCAGGTGCAATGATCTTCTG 
HF34 CACATGGGTGCCCAACTGC HR-34 CGTCGGAGAAGAAGAAGGG 
HF35 CACCGCCCCCCACCGTGT HR-35 CCAATGGCCAATTCCTCAAA 
HF36 GTGCGGAGACATACTGCC HR-36 CCGTGCTGCTACAGCGGCC 
HF37 GATCATTGCACCTGAGAA HR-37 GACTGGAGAGCGAGTCGGAG 
HF38 GATCATTGCACCTGAGAA HR-38 GAGCTGTTTCTCTGCTCTCTC 
HF39 GACGAGGCCAAGCCCTGGT HR-39 CTTGACCAGCCACTCGCC 
HF40 AAGGACCCAGTCCTTGTGG HR-40 CTTGGCGCGCGTTGTCGAGCC 
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HF41 CCCCCGTCTTCAGTTTCGG HR-41 GCCACGGAGGCAAACGACCAC 
HF42 CAGCTCAAAGCACGTGAC HR-42 CAGGGTCAGGCGGGCAGTACC 
HF43 GCATGGATCGCCTCAGAAG HR-43 AACCTTGCTGTTGAAAGGT 
HF44 CCAAGGAGTGGCTCGACAA HR-44 GAGCTTTGATTATGTCCAAT 
HF45 CCAACCTGTGCAAAGTGG HR-45 AACCCGATCAATCACCTCCTG 
HF46 TCCTTGCGAACGTGCTCGC HR-46 GAATTCAATTGCTGCTTCGTG 
HF47 CACGGGGTTCATCCCGCC HR-47 AAGTTCTCCTTCAGGCGC 
HF48 AAGGTTTCACTTTGACAT HR-48 CATGATCACTATGTTTGCC 
HF49 ATGAAGAGAATGCAACAA HR-49 GAAACCAACAGTGCTGGCACC 
HF50 AATTCCTTCCCAAAAGTC HR-50 GGCGGGCTCGGAGTTCAC 
HF51 GTTTAAGCGCCTGAAGGA HR-51 CTTTCAGTGGTTTCTGTCTCTCC 
HF52 TAGTGATCATGATCCGCGA HR-52 CGTCGAGGATGAGCTCAACAGGC 
HF53 AGACTAGTGGTGCCAGCAC HR-53 CCTTTTACTTTAATCTCAAACTC 
HF54 CTGAAGGACCCTACGCCGG HR-54 GGGTGCCTTTCTTCATTCTTGC 
HF55 ACAGAAACCACTGAAAGTG HR-55 CCAGGCATGGTGTCTCCATCC 
HF56 TACGAGGGACCGGTGAAG HR-56 GCAGTATCCAACTCCATTGCC 
HF57 CGACTTGCAAAAGATGGT HR-57 CTCTTCCACATCTCTGGTGTC 
HF58 CTACCTCGTGCCTCGTCA HR-58 GTGTTTGGAGAAGATGAC 
HF59 AAAGGACAGGACATGCTC HR-59 CGCCGCGGCGTTTCCCCTGGAG 
HF60 CGTGATCAACAACGCCGA HR-60 GCGAGTCTTGCCGGCACG 
HF61 CACCAAGGCTGGCTACTG HR-61 CTTTGCCAATCAACATCAGG 
HF62 GAAGATGAAGGCACACAT HR-62 CTGTGCGGAACACCTCCTC 
HF63 CGCTGCCGACTACGCGTC HR-63 CAGAATTGTGTTGATGATGC 
HF64 ACGCCATGGAACCAGACAC HR-64 CACTTGCAACCACGATGTC 
HF65 TCGACTTCGAGAACGGCACGG HR-65 CAGCTGGAGTGATGGTTTG 
HF66 CTTGTCAGACCTTCCTGAA HR-66 GGATAGCCTCGAGGGTCTTCG 
HF67 CACCAGGATGATGATTGGCAG HR-67 CTCATCAGGTCCAGAGTGGAC 
HF68 TTCGGCCTTTGATGCTAA HR-68 CACACGGCGTTCACCCAACGC 
HF69 AGTGGATTCTGAAGACTCT HR-69 TTTTTTTTTTTTTTGGAATAGG 
HF70 ACATCTACGTGCTCTACGC HR-70 TTTTTTTTTGAAATAGGTAGCGGGAAA 
HF71 TGAGCTGGACACTTACACC   
HF72 TTTGTTCTTGGTCACTCCAT   
HF73 TTACAAACCTGTGATGGC   
HF74 TCTCTTTGAGATTCCAAGC   
 
 
 
 
 
 
